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Sleep fragmentation induces acute inflammation and increases 
glucocorticosteroids in vertebrates. Obesity and sleep fragmentation are often concurrent 
pro-inflammatory conditions in patients with obstructive sleep apnea.  Despite the 
association between the two, their simultaneous effects on immune and endocrine profiles 
have not been explored.  In the first experiment, we investigated changes in pro-
inflammatory (IL-1β, TNF-α) and anti-inflammatory (TGF-β1) cytokine gene expression 
in the periphery (liver, spleen, fat, and heart) and brain (hypothalamus, prefrontal cortex, 
and hippocampus) in mice exposed to various intervals of sleep fragmentation. Serum 
corticosterone concentration was also assessed. Sleep was disrupted in male C57BL/6J 
mice using an automated sleep fragmentation chamber (Lafayette Industries), which 
involved movement of a sweeping bar at specified intervals. Mice were exposed to bar 
sweeps every 20 sec (high sleep fragmentation; HSF), 120 sec (low sleep fragmentation; 
LSF), or the bar remained stationary (control). Trunk blood and tissue samples were 
collected after 24 h of SF. It was found that HSF is a potent inducer of inflammation in 
the periphery (IL-1β: adipose, heart, and hypothalamus), but leads to upregulation of anti-
inflammatory cytokines in the brain (TGF-β1: hypothalamus and hippocampus), despite 
elevated serum corticosterone. Due to the association between obesity and SF, this 
experiment was replicated in male C57BL/6J mice (lean) and ob/ob KO mice (obese) 
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using the previously described methods.  We predicted the acute inflammatory response 
resulting from HSF would be different for the lean and the obese mice, with the greatest 
cytokine gene expression levels in the OB HSF group, due to a summative effect of the 
pro-inflammatory conditions.  Obesity was the factor that most affected cytokine gene 
expression profiles. Additionally, the pro- vs anti-inflammatory gene expression profile 
varied with tissue type. While obesity resulted in neuroinflammation (hypothalamus, 
prefrontal cortex, hippocampus), it led to decreases in pro-inflammatory cytokine gene 
expression in the periphery (spleen, fat, heart). Serum corticosterone concentration was 
significantly elevated due to SF, but was not affected by obesity. As a result, the obese 
mice likely had neuroendocrine adaptations to combat the pre-existing pro-inflammatory 
condition of obesity, which impacted the acute inflammatory response to sleep loss.  
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INTRODUCTION 
 
Sleep is a conserved physiological process that consumes a large portion of 
mammalian life spans, although its precise function has produced considerable debate. A 
recent study has  suggested that time spent sleeping promotes the clearance of metabolic 
wastes from the brain through the cleansing of cerebral spinal fluid (Xie et al., 2013). A 
reduction in the amount of time spent sleeping curtails this cleansing period, which could 
result in well-documented impairments in learning and memory, as well as an elevated 
risk in developing chronic disease associated with inflammation, such as cardiovascular 
disease, insulin resistance, and obesity (Graves et al., 2003; Markwald et al., 2013; 
Zielinski et al., 2013). Emerging evidence indicates that sleep quantity and quality 
facilitate the maintenance of neurocognitive function and health, which ultimately 
contribute to lower morbidity and mortality rates (Simpson and Dinges, 2007). In recent 
years, fewer people are getting the suggested 7 to 9 hours of sleep a night, likely due to 
increases in shift work labor, sleep loss, or sleep disordered breathing associated with the 
worldwide rise in obesity. Since sleep influences memory and cognitive ability, hormone 
secretion, glucose metabolism, immune function, core body temperature, and renal 
function, adverse health outcomes have been observed after chronic sleep disturbance 
(Nair et al., 2011; Simpson and Dinges, 2007; Zielinski et al., 2013). Ample experimental 
evidence has demonstrated that disrupted sleep contributes to hypertension, diabetes, 
obesity, depression, and stress, all of which are linked to pro-inflammatory conditions 
(Naidoo, 2012). 
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Under normal conditions, the immune system varies throughout the day in 
conjunction with the sleep-wake cycle. Immune cells in the blood exhibit maximum 
levels in the early evening and reach minimum circulating levels in the morning 
(Simpson and Dinges, 2007). Correspondingly, pro-inflammatory cytokine levels 
coincide with this cycle and approach maximum levels at night, most often times during 
slow wave sleep (Besedovsky et al., 2012; Simpson and Dinges, 2007). The increase in 
pro-inflammatory cytokines at the beginning of rest is hypothesized to be a result of the 
accumulation of endogenous ‘danger signals’ during waking; however, this is only a 
proposed mechanism (Besedovsky et al., 2012). Because of the fluctuation in cytokine 
gene expression, amount and quality of sleep have important effects on immunological 
integrity, such that disruption of the normal sleep wake cycle results in altered immune 
function in humans and other mammals. In a normal immune response, an acute 
inflammatory response induces activation of an immune cascade in response to perceived 
damage or infection to generate an antigen specific response. Detection of pathogen or 
danger associated molecular patterns (PAMPs or DAMPs) occurs by means of binding of 
ligands to the leucine rich repeat domains of toll-like receptor proteins (TLRs) expressed 
on macrophages or other immune cells (Murphy, 2012). Binding to the TLR induces 
dimerization of the receptors and a signaling cascade that ultimately brings about the 
production of pro-inflammatory cytokines, such as Interleukin-1β (IL-1β), Tumor 
Necrosis Factor alpha (TNF-α), and Interleukin-6 (IL-6), via the Nuclear Factor Kappa B 
(NFKB) pathway (Murphy, 2012).  
There is growing evidence demonstrating that sleep is influenced by hormones 
and peptides, known as sleep regulatory substances (SRSs). SRSs are chemicals of 
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varying molecular sizes that act as neurotransmitters, neuromodulators, or 
neurohormones to participate in the generation and maintenance of the sleep-wake cycle 
(Garcia- Garcia et al., 2014). Current research holds that a number of molecules may play 
a role in sleep regulation, including: IL-1β, TNF-α, growth factor releasing hormone, 
prolactin, and nitric oxide (Garcia- Garcia et al., 2014). Experimentally, it has been 
demonstrated that the SRS peptides accumulate within the brain and cerebrospinal fluid 
(CSF) during prolonged wakefulness, such that CSF or brain extracts taken from a sleep 
deprived animal promote sleep when injected into a non-sleepdeprived animal (Clinton et 
al., 2011; Garcia – Garcia et al., 2009; Obal and Krueger, 2003). In addition to having 
pro-inflammatory roles as previously described, IL-1β and TNF-α  also function as sleep 
regulatory substances (SRS) released by activated microglia that help regulate non-rapid 
eye movement sleep (Baracchi and Opp, 2008; Clinton et al., 2011). In one proposed 
mechanism of SRS function, IL-1β and TNF-α are released from glia in response to 
extracellular ATP. The cytokines then bind to receptors on neurons, resulting in 
neuromodulator and neurotransmitter receptor up and downregulation, ultimately 
bringing about alterations in neuronal excitability and function to promote state changes 
in the local neuronal network (Jewett and Krueger, 2012).  Supporting this mechanism is 
previous experimental evidence that has shown elevated IL-1β expression in the mouse 
brain following sleep deprivation; however, it must be noted that the expression of TNF-
α has varied depending upon the study (Chennaoui et al., 2011; Weil et al., 2009;  
Zielinski et al., 2014).   Additional experiments have expanded upon this idea and have 
shown the injection of IL-1β and TNF-α in animal models increases the amount of time 
spent in NREM sleep (Baracchi and Opp, 2008). Growing evidence supports that 
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recurrent sleep interruptions induce excessive daytime sleepiness via activation of 
inflammatory mechanisms in a TNF-α dependent pathway (Ramesh et al., 2012). 
Furthermore, because of the role of IL-1β and TNF-α as SRSs, these molecules can 
promote NREM sleep and induce symptoms of sleep loss, such as sleepiness, fatigue, and 
poor cognition (Jewett and Krueger, 2012).  
Following a period of sleep curtailment, upregulation of the immune response 
results, but is not associated with pathogenic challenge (Brager et al., 2013).  Sleep loss 
does not need to be drastic to induce effects on the immune system, as one study 
demonstrated that with only 4-8 hours of sleep deprivation, there was a significant 
decrease in natural killer (NK) cell activity (Simpson and Dinges, 2007).  Other studies 
have shown increases in the pro-inflammatory cytokines after just one night of 
insufficient sleep (van Leeuwen et al., 2009). The non-specific host immune response is 
characterized by an increase in the number of leukocytes, monocytes, granulocytes, 
increased cytotoxicity of the NK cells, and decreases in immunoregulatory cytokines, 
such as IL-4 and IL-10 (Hirotsu et al., 2012; Mullington et al., 2010; van Leeuwen et al., 
2009).  In addition to an increase in the number of immune cells, there is also activation 
and translocation of NFKB in specific brain regions associated with sleep regulation (Kim 
et al., 2011).  This then leads to the production of pro-inflammatory cytokines. There 
have been numerous cytokines and chemokines hypothesized to affect sleep, including; 
IL-1α, IL-1 β, IL-2, IL-4, IL-6, IL-8, I-10, IL-13, IL-15, IL-18, TNF-α, TNF-β, IFN-α, 
IFN-β, IFN-β and macrophage inhibitory protein 1b (Kim et al., 2011). However, of 
these, experimental models have repeatedly shown increases in expression of the pro-
inflammatory cytokines IL-1β and TNF-α in the brain following sleep deprivation 
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(Ashley et al., 2013; Kaushal et al., 2012b; Majde and Krueger, 2005).  In the periphery, 
increases are observed in IL-1β, IL-6, and TNF-α gene expression (Ashley et al., 2013; 
Brager et al., 2013). More recently, IL-17 has been identified as another pro-
inflammatory cytokine upregulated by sleep restriction (van Leeuwen et al., 2009). 
Furthermore, it has also been demonstrated in human vaccination experiments that sleep 
plays a critical role in the formation and maintenance of immunological memory, such 
that sleep loss results in diminished antibody production (Besedovsky et al., 2012).   
Although immunoregulatory cytokines such as IL-4 and IL-10 have been studied 
extensively in relationship to sleep deprivation, TGF-β1 expression, an anti-inflammatory 
cytokine involved in the regulation of cell growth, proliferation, differentiation, and 
apoptosis, remains largely unstudied in this context (Murphy, 2012).   
Because many pro-inflammatory cytokines are present following sleep alterations, 
it is understood that insufficient sleep leads to initiation of an acute inflammatory 
response. However, the mechanism underlying the induction of an inflammatory response 
has yet to be elucidated. One possible hypothesis includes the reaction to an increase in 
endogenous danger signals, such as reactive oxygen species, nucleotides, and heat shock 
proteins, released as a result of various cellular stresses from physical activity, 
metabolism, and cell injury during the active wake cycle (Besedovsky et al., 2012). 
Additional experimental results highlight TLR4 as being involved in the inflammatory 
response to sleep loss (Wisor et al., 2011). TLR4 initiates a signaling cascade in response 
to detection of lipopolysaccharide (LPS) or endogenous ligands, then results in an 
increased release of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) and other pro-
inflammatory agents, such as nitric oxide, cyclooxygenase, prostaglandin E2, and 
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adenosine triphosphate (Wisor et al., 2011). Because all of these molecules are known to 
play roles in regulating the timing of sleep/wake cycles, it helps support the proposed 
relationship between inflammation modulated by TLR4 and sleep loss. In addition, there 
is upregulated expression of TLR-2 and TLR-4 in patients with obstructive sleep apnea 
(Akinnusi et al., 2013). However, subsequent investigations to further elucidate this 
mechnism are lacking. In lieu of this deficiency, additional studies have utilized 
inflammation mediated by TLR4 in response to sleep loss as a model to show increased 
pathogenesis as a result of inflammation following sleep loss. It has been demonstrated 
that within the context of cancer, fragmented sleep accelerates tumor growth and 
progression through TLR4 signaling (Hakim et al., 2014). Furthermore, TLR4 expression 
on macrophages is upregulated in obstructive sleep apnea patients before administration 
of breathing treatment (Akinnusi et al., 2013). Additional experimentation demonstrated 
that TLR4 signaling changes with age, as there is a decrease in TLR4 mediated 
inflammation to sleep loss in adults in comparison to young people (Carroll et al., 2015). 
Because inflammation mediated by TLR4 signaling following sleep interruptions in each 
of these conditions exacerbates disease pathology, these experiments support the 
hypothesis that inflammation following sleep curtailment involves TLR4 signaling.   
Not only does insufficient sleep lead to an increase in the number of immune cells 
and an upregulation in cytokine gene expression, but it also stimulates changes in other 
protein and hormone levels. Because sleep deprivation is associated with the 
development of chronic disease, such as cardiovascular disease and diabetes, recent 
studies have investigated the association between sleep loss and C-reactive protein (CRP) 
levels (van Leeuwen et al., 2009). CRP is an acute phase protein, an inflammatory signal 
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released by the liver that is commonly used as a marker indicating cardiovascular risk 
(Murphy, 2012). It has been observed that CRP levels increase with both partial and total 
sleep deprivation (Simpson and Dinges, 2007).  Consequently, this suggests that sleep 
alteration may result in elevated risks for developing cardiovascular disease.  
 
Figure 1. Schematic diagram showing the proposed links between sleep fragmentation of 
obstructive sleep apnea and the onset of cardiovascular disease (Modified from Pak et al., 
2014). 
Additionally, it has been demonstrated in mice that chronic sleep fragmentation 
induces endothelial dysfunction through elastic fiber disruptions in thoracic and arch 
regions of the aorta (Carreras et al., 2014).  Compounding the risk for the onset of 
cardiovascular disease is the fact that chronic sleep fragmentation, attributable to 
bstructive sleep apnea, leads to an increase in the expression of cell adhesion molecules, 
such as ICAM-1 and VCAM-1, which then help contribute to the endothelial dysfunction 
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(Pak et al., 2014).  Cardiovascular disease may arise following chronic periods of sleep 
interruptions due to the increase in CRP levels, the disruption of vessel wall integrity, and 
the increase in cell adhesion molecules, all of which help favor the progression towards 
atherosclerosis. 
More recently, it has been found that insufficient sleep affects food intake, as 
sleep loss results in alterations in satiety hormone concentrations that can ultimately 
result in weight gain. Results indicate that concentrations of ghrelin, a hunger signaling 
hormone, and leptin and peptide YY, satiety signaling hormones, are changed following 
insufficient sleep (Garcia-Garcia et al., 2014). Following sleep alterations, caloric intake 
increases in conjunction with rises in circulating ghrelin and corresponding decreases in 
leptin and peptide YY concentrations (Garcia-Garcia et al., 2014; Markwald et al., 2013; 
Mavanji et al., 2012). The increase in food intake following sleep deprivation is thought 
to be in response to elevated energetic demands due to prolonged wakefulness; however, 
because caloric expenditure does not change, and because glucose clearance and insulin 
sensitivity in adipocytes decrease with time following sleep restriction, the surplus 
calories become stored as fat (Markwald et al., 2013; Wang et al., 2014; Zhang et al., 
2014). Whereas increased food intake leads to weight gain in chronic sleep fragmentation 
studies, previous experimentation also demonstrated that rodents experience a decrease in 
weight until day 7 of a chronic sleep fragmentation experiment, indicating the 
experimental time period may have some effect on this observation (Baud et al., 2013).  
Other literature indicated that even though altered glucose homeostasis is observed 
following two weeks of chronic sleep fragmentation, body weight changes are absent; 
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thereby suggesting the period of chronic sleep interruptions must exceed two weeeks 
before weight changes are apparent (Carreras et al., 2014).   
Obesity is described as a pro-inflammatory condition; however the underlying 
cause of this inflammation has not yet been determined. Previous literature has attributed 
the increase in pro-inflammatory cytokines to cytokine recruitment following 
macrophage infiltration into adipose tissue (Chawla et al., 2011). Macrophages are 
phagocytic cells of the immune system that ingest cellular debris and pathogens. The 
engulfment of particles by macrophages can result in the stimulation of lymphocytes and 
other immune cells to respond to the presence of a pathogen (Murphy, 2012). It is now 
known that there are two distinct subsets of macrophages, each of which has its own 
function in the inflammatory response. The M1 macrophages, the classically activated 
macrophages, are stimulated by the presence of Pathogen Associated Molecular Patterns 
(PAMPs) or Damage Associated Molecular Patterns (DAMPs) as detected by Toll Like 
Receptors (TLRs) or by the presence of TH1 type cytokines, such as IFN-γ (Chawla et al., 
2011). M1 macrophages promote inflammatory responses through the secretion of pro-
inflammatory cytokines, such as IL-6 and TNF-α (Murphy, 2012).  Conversely, the M2 
macrophages are alternatively activated macrophages that are activated by TH2 cytokines, 
such as IL-4 and IL-13 (Chawla et al., 2011). These macrophages are associated with 
tissue repair and the down regulation of inflammatory responses (Murphy, 2012).  
There is greater polarization towards M1 macrophage infiltration in the adipose 
tissue of obese individuals, whereas M2 macrophages are found in the adipose tissue of 
lean individuals (Chawla et al., 2011). Similarly, it has been shown in an experimental 
model of chronic sleep fragmentation that there is greater polarization towards the M1 
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macrophage subtype in visceral white adipose tissue following sleep fragmentation, 
leading to a skewed M1/M2 subtype ratio (Carreras et al., 2015).   This difference 
suggests that the increased infiltration of M1 macrophages into adipose tissue is 
associated with the increase in pro-inflammatory cytokine expression. Further 
investigations into the maintenance of metabolism have elucidated potential mechanisms 
by which obesity and inflammation result in insulin resistance. Recent literature has 
suggested that superoxide and reactive oxygen species generated by the nicotinamide 
adenine dinucleotide phosphate oxidase-2 (NOX-2) enzyme in macrophages are the 
causative agents of tissue damage and inflammation, ultimately leading to systemic and 
adipose tissue insulin resistance (Zhang et al., 2014). Because the activity of the NOX-2 
enzyme increases following sleep fragmentation, the damage due to oxidative stress 
results in glucose intolerance and reduced insulin sensitivity with time of exposure to 
sleep fragmentation (Zhang et al., 2014).  
The combination of the oxidative stress induced by NOX-2 activity and 
polarization towards the M1 macrophage subtype leads to a persisting, non-specific 
inflammatory response characterized by an increase in pro-inflammatory cytokines (e.g.,  
IL-1β, IL-6, TNF-α). If the inflammatory condition persists, then tissue damage will 
result from the cytotoxic products of the inflammatory state. The cell-mediated products 
recruited by the cytokines of chronic inflammatory responses have been implicated in the 
development of diseases such as hypertension, diabetes, and obesity, all of which have 
been observed as adverse consequences of sleep curtailment (Murphy, 2012).  
Furthermore, curtailment of the sleeping period results in an increase in stress 
hormones (Neto et al., 2010). In addition to activating the sleep homeostatic process, 
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sleep deprivation models also activate the hypothalamic-pituitary-adrenal (HPA) axis, 
leading to the release of adrenocorticotropic hormone (ACTH) from the anterior pituitary, 
which then acts on the adrenal cortical cells to bring about an increase in glucocorticoids 
in the circulation (Mongrain et al., 2010). The increase in stress hormone levels 
(corticosterone for rodents and cortisol in humans) has the potential to influence the 
resulting hormone levels, as corticosteroids have an anti-inflammatory effect at chronic 
levels (Miyata et al., 2015; Mongrain et al., 2010).  
 
 
Figure 2. Schematic illustration of the proposed mechanism for tissue damage by means 
of the increased activity of NOX-2 following sleep fragmentation. 
The majority of studies investigating the immunomodulatory role of sleep have 
utilized a total sleep deprivation method in mice and humans, in which the test subject is 
prevented from sleeping for an extended period of time (Ashley et al., 2013; Baracchi and 
Opp, 2008; Brager et al., 2013: Hirotsu et al., 2012). However, a compounding factor 
when using this model is stress induced by the sleep deprivation process itself. When 
compared to total sleep deprivation, the sleep fragmentation model induces lower serum 
corticosterone concentrations within the model organism, ultimately better simulating the 
result of a single night of interrupted sleep experienced by patients with sleep apnea and 
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other sleep disorders (Kaushal et al., 2012b). Over time, the acute effects of sleep 
fragmentation become chronic effects, thereby contributing to the chronic exposure to 
inflammatory compounds observed in patients with sleep apnea. As a result, there is a 
need to better characterize the initial response to sleep interruptions and the link it has 
with the progression to pathology over time, such that measures can be taken to prevent 
this progression from occurring. Although there is evidence linking sleep deprivation to 
an elevated immune state, there has been little investigation into whether intermittent 
sleep can diminish the acute inflammatory response initiated by sleep loss. Previous 
research has shown that sleep homeostatic responses associated with acute total sleep 
deprivation cannot be generalized to the response associated with acute sleep 
fragmentation, due to the fact that sleep loss in sleep fragmentation is markedly smaller 
(Ramesh et al., 2009). For this reason, the sleep fragmentation model has been chosen for 
these studies.  
Recently, there has been doubt cast upon the accuracy of using murine models for 
human inflammatory diseases.  It has been shown that genomic responses in mouse 
models poorly mimic human inflammatory diseases, particularly in trauma and burn 
conditions (Seok et al., 2013). Despite this concern, for sleep deprivation studies, it has 
been repeatedly shown that the murine model is the closest approximation of the human 
inflammatory response resulting from sleep deprivation (Baracchi and Opp, 2008; Brager 
et al., 2013; Majde and Krueger, 2005). Thus, for the purpose of this study, the murine 
model persists as the most reliable model for the human immune response, apart from 
using human subjects.  
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The aim of this study was to examine the effects of acute sleep fragmentation on 
pro-inflammatory (IL-1β and TNF-α) and anti-inflammatory (TGF-β1) cytokine gene 
expression in brain and peripheral tissue of a murine model, as well as serum 
corticosterone concentration, to determine whether the degree of sleep fragmentation 
alters the development of an inflammatory response to sleep loss. IL-1β and TNF-α were 
chosen as the pro-inflammatory cytokines of interest for this experiment due to the 
known roles as major pro-inflammatory cytokines and also as sleep regulatory substances 
affecting the sleep wake cycle (Jewett and Krueger, 2012).  TGF-β1 was chosen because 
of its role as an anti-inflammatory cytokine that is widely expressed in many tissues. The 
majority of previous sleep studies have investigated IL-10 gene expression; however, 
TGF-β1 was chosen such that novel information may be uncovered. Recent literature 
supports selecting these cytokines, as it has been  demonstrated that both TNF-α and 
TGF-β1 play a role in the regulation of clock gene expression, implicating them as 
effectors of circadian gene expression (Lopez et al., 2014).We hypothesized that mice 
exposed to a “high” sleep fragmentation model (HSF), with sleep disruptions occurring 
every 20 seconds, would exhibit an increase in pro-inflammatory cytokine gene 
expression (IL-1β and TNF-α), an increase in serum corticosterone concentrations, and a 
decrease in anti-inflammatory cytokine (TGF-β1) gene expression in both the brain and 
periphery. Mice experiencing a lower frequency of sleep fragmentation (LSF), with sleep 
interruptions occurring every 2 minutes, were also hypothesized to display upregulated 
pro-inflammatory cytokine gene expression, downregulated anti-inflammatory gene 
expression, and increased serum corticosterone concentrations; however, these levels 
were predicted to be intermediate between those of control and HSF groups.  
  
14 
MATERIALS AND METHODS 
Animals  
Male C57BL/6J mice (n = 35) were housed in a colony room (12 h light/ 12 h dark, lights 
on 07:00 h; 21°C ± 1°C) at Western Kentucky University. After weaning at 21 d of age, 
mice resided in polypropylene cages with same sex littermates and were provided 
corncob bedding, as well as food, and water ad libitum. This study was conducted under 
approval of the Institutional Animal Care Committee at Western Kentucky University 
and procedures followed the National Institutes of Health Guide for the Use and Care of 
Laboratory Animals and international ethical standards.  
 
Sleep fragmentation 
Adult( >8 weeks of age) male mice were selected for experimentation and were briefly 
exposed to isoflurane vapors and weighed to the nearest 0.01 g. Mice ranged in age from 
23 weeks – 33 weeks.  Four mice were then placed in an automated sleep fragmentation 
chamber (Lafayette Industries, Lafayette, IN USA; Model 80391) with a thin layer of 
corn cob bedding at 09:00 h. Food and water were provided ad libitum. To distinguish 
among subjects, tails were marked with a different colored pen (Sharpie). At 8:00 the 
next day, the swipe bar was activated. The chamber (9.625”L x 8.25”W x 7.75”H) 
resembled a typical polypropylene cage, with the addition of an automated swipe bar that 
moves horizontally across the cage at set intervals. Thus, this interval reflects a state of 
sleep fragmentation rather than sleep deprivation and will be referred to as “high” sleep 
fragmentation (HSF) when set at 20 seconds and “low” sleep fragmentation (LSF) when 
set at 120 seconds (Ramesh et al., 2009; Ringgold et al., 2013). For the control group, the 
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bar remained stationary. Thirty-six mice were randomly assigned to either control (n = 
12), LSF (n = 11), or HSF (n = 12) groups. One mouse was removed from the LSF group 
because it climbed into the food hopper unexpectedly and was found asleep there the 
following morning.  
 After HSF, LSF, or control conditions for 24 h, animals were deeply anesthetized 
using isoflurane vapors (< 2 min), weighed, and then rapidly decapitated within 3 min of 
initial handling. Trunk blood was collected, kept on ice for < 20 min, and then spun at 
3000 x g for 30 minutes at 4°C. The serum was drawn off and stored at -80°C for later 
ELISA analysis.  Liver, spleen, inguinal fat, and heart samples were collected and placed 
into Eppendorf tubes containing RNAlater solution (Life Technologies). The tissue 
samples were stored at 4°C until RNA extraction was performed. The hypothalamus, 
prefrontal cortex, and hippocampus were then dissected from the brain and stored in 
RNAlater at -20°C until RNA extraction. Target tissues were chosen based upon their 
known roles in immune function, sleep, and involvement in the pathologies associated 
with chronic sleep fragmentation. 
 
RNA Extraction  
RNA was extracted from brain, liver, spleen, and fat using an RNeasy Mini Kit (Qiagen). 
RNA was extracted from the heart using an RNeasy Fibrous Tissue Mini Kit. RNA 
concentration was measured using a NanoDrop 2000 Spectrophotometer (Thermo 
Scientific). 
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Reverse Transcription  
Total RNA was reverse transcribed into cDNA using a High-Capacity cDNA Reverse 
Transcription kit (Life Technologies, #4368813). The total RNA concentration of the 
tissue was diluted (brain: 9.2 and 10.1 ng/µL; liver, spleen, and fat: 10.2 ng/µL; heart: 
22.6 ng/µL). The reaction was carried out according to the manufacturer’s instructions. 
The amplification conditions for the thermocycler were 25°C for 10 min, 37°C for 120 
min, 85°C for 5 min (for 1 cycle), and then 4°C .   
 
RT-PCR 
Real Time- PCR was performed using an ABI 7300 RT-PCR System. To determine 
relative cytokine gene expression, Taqman Gene Expression RT-PCR Master Mix and 
the following primer/probes (Applied Biosystems) were used: IL-1β (Mm00434228_m1), 
TNF-α (Mm00443260_g1), and TGF-β (Mm01178820_m1), or 18s endogenous primer-
limited (Mm03928990_g1). Cytokine probes were labeled with the fluorescent marker 5-
FAM at the 5’ end and the quencher MGB at the 3’ end. The 18s endogenous control 
used a VIC-labeled probe. The amplification conditions were 50°C for 2 min, 95°C for 
10 min, 40 cycles of 95°C for 15 seconds, and 60°C for 1 min.  The reaction was carried 
out according to the manufacturer’s instructions, and allowed for the determination of the 
relative expression of IL-1β, TNF-α, and TGF-β by comparison with the standard curve 
generated using serial dilutions of pooled cDNA (1:1, 1:10, 1:100, 1:1000, 1:10000) and 
normalization to the control 18s ribosomal RNA levels. 
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ELISA  
Serum corticosterone concentration was determined using an ELISA kit (ab108821; 
Abcam) with 96% recovery for corticosterone (0.3 ng/mL sensitivity). The reagents and 
standards were prepared according to the manufacturer’s instructions. Cross reactivities 
for the kit were < 30% deoxycorticosterone, < 2% aldosterone, < 2% progesterone, and < 
1% cortexolone.  Per the manufacturer’s instructions, serum samples were diluted 1:200. 
The reaction was carried out in duplicate according to the kit instructions and the average 
absorbance of the plate was determined using a plate reader and subtracting the 
absorbance at 450 nm from the absorbance at 570 nm (BioTek Synergy H1 Hybrid 
Reader). Corticosterone concentrations were extrapolated from a standard curve using a 
four-parameter logistic curve fit (Graphpad Prism) and multiplying by the dilution factor 
(1:200). The intraassay variation was 5.0% CV.   
 
 Statistical Analyses  
All data are expressed as mean ± standard error (SE). One-way ANOVAs were used to 
detect differences among groups, with sleep treatment (control (no SF), LSF, and HSF) as 
the main factor and relative gene expression of specific cytokine as the dependent 
variable. Post hoc tests were carried out using a Tukey-Kramer HSD test. In some cases, 
logarithmic transformation was necessary to satisfy requirement of homogeneity of 
variances; in other cases, non-parametric tests were required (Kruskal Wallace H tests). 
For the latter, Mann-Whitney U tests were used to evaluate differences between 
experimental groups and a Bonferroni correction was employed to correct from the 
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number of comparisons made. Statistical analyses were carried out using SPSS and 
Statview programs.  
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RESULTS 
Highly fragmented sleep decreases body mass  
Body mass was significantly decreased following 24 hours of experimentation (one-way 
ANOVA; F2,32 = 10.513, p = 0.0003; Fig.3). Post-hoc tests revealed that body mass loss 
was significantly different between the control (-1.14 g ± 0.25 g; mean ± SE) and HSF (-
2.67 g ± 0.32 g; mean ± SE) groups (p < 0.05, Fig.3) and between the HSF and LSF (-
1.29 g ± 0.17 g; mean ± SE) groups (p < 0.05, Fig.3). However, there was no significant 
difference in body mass loss between the control and LSF groups (p > 0.05, Fig.3). 
 
 
 
 
 
 
 
 
Figure 3. HSF induces changes in body mass after 24 hours. Data are shown as mean 
body mass lost (g) ± SE for each group. Shared letters indicate no significant difference 
between groups.  The numbers at the base of the column indicate the sample size of each 
group.  
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Figure 4.  SF increases IL-1β gene expression in inguinal adipose tissue. Data are shown 
as mean ± SE for each group. Gene expression was undetectable by RT-PCR in some 
tissue samples, resulting in a decreased sample size in these groups.  Shared letters 
indicate no significant difference between groups. Since the results are marginally 
significant for TNF-α gene expression in the inguinal adipose tissue, all bars share the 
same letter.  The numbers at the base of the column indicate the sample size of the group. 
 
Sleep fragmentation increases IL-1β gene expression in adipose tissue 
 LSF and HSF increased IL-1β gene expression in adipose tissue relative to controls (one-
way ANOVA; log-transformed; F2,26 = 9.387, p = 0.0009; p < 0.05; Fig.4). Post-hoc tests 
revealed that IL-1β gene expression was similar between SF groups (p > 0.05, Fig. 4). In 
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contrast, there were no significant differences detected in the liver (Kruskal Wallis; H = 
2.364, p = 0.3067, Fig.4) or spleen (Kruskal Wallis; H = 0.770, p = 0.6805, Fig.4).  There 
was a trend for elevation of TNF-α gene expression in adipose tissue of SF mice relative 
to controls (one-way ANOVA; log-transformed, F2,26 = 3.231, p = 0.0546; Fig.4), but 
there was no significant difference detected in the liver (one-way ANOVA; log-
transformed, F = 1.529, p = 0.2410, Fig.4) or spleen (Kruskal Wallis; H = 2.550, p = 
0.2794, Fig.4). TGF-β1 gene expression did not differ in the liver (Kruskal Wallis; H = 
1.872, p = 0.3921, Fig.4), spleen (one-way ANOVA; F2,31 = 1.936, p = 0.1637, Fig.4), or 
adipose tissue (Kruskal Wallis; H = 3.681, p = 0.1588, Fig.4).  
 
Sleep fragmentation increases IL-1β gene expression in heart tissue  
A significant difference in IL-1β gene expression was detected in cardiac muscle tissue 
following high sleep fragmentation (one-way ANOVA; log-transformed, F2,32 = 7.525, p 
= 0.0021, Fig.5). Post hoc analysis revealed a significant difference in IL-1β gene 
expression between the HSF group and the control (p < 0.05), but there was similar gene 
expression between the LSF group and the control (p > 0.05) and between LSF and HSF 
(p > 0.05). No differences in TNF-α gene expression (one-way ANOVA; log-
transformed, Fig.5) or TGF-β1 gene expression (one-way ANOVA, Fig.5) were detected 
in the heart (all p > 0.44).  
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Figure 5. HSF induces an increase in the gene expression of IL-1β in cardiac muscle 
tissue. Data are shown as mean ± SE for each group. Shared symbols indicate there is no 
significant difference between groups. The numbers at the base of the columns indicate 
the sample size. 
 
Sleep fragmentation increases cytokine gene expression in the hypothalamus  
IL-1β gene expression varied significantly among groups in the hypothalamus (Kruskal 
Wallis; H = 7.212, p = 0.0272, Fig.6), but not in prefrontal cortex (Kruskal Wallis; H = 
1.938, p = 0.3794, Fig.6) or hippocampus (one-way ANOVA; F2,31 = 0.743, p = 0.4840, 
Fig.6). More specifically, hypothalamic IL-1β gene expression increased in LSF relative 
to HSF mice (Mann Whitney; U= 24; Z = -2.374; p = 0.0176; adjusted α = 0.017, Fig.6). 
However, there was no difference between LSF and control mice (Mann Whitney; U = 
25, Z = -2.308, p = 0.0210, Fig.6) or between the control and HSF mice (Mann Whitney; 
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U = 69, Z = -0.173, p = 0.8625, Fig.6). There was no significant difference in TNF-α 
gene expression in the hypothalamus (Kruskal Wallis; H = 2.455, p = 0.2930, Fig.6), 
prefrontal cortex (Kruskal Wallis; H = 2.002, p = 0.3675, Fig.6), or hippocampus 
(Kruskal Wallis; H = 1.341, p = 0.5115, Fig.6). Sleep fragmentation induced significant 
alterations in TGF-β1 gene expression among groups in the hypothalamus (Kruskal 
Wallis; H = 15.132, p = 0.0005, Fig.6) and hippocampus (one-way ANOVA; F2,32 = 
4.060, p = 0.0268, Fig.6).  There was a trend for increased gene expression in the 
prefrontal cortex (Kruskal Wallis; H = 5.651, p = 0.0593, Fig.6). Post hoc tests revealed 
TGF-β1 hypothalamic gene expression was significantly different between LSF and HSF 
groups (Mann Whitney; U = 8, Z = -3.429, p = 0.0006, Fig.6) and between HSF and 
control groups (Mann Whitney; U = 28, Z = -2.540, p = 0.0111, Fig.6). However, LSF 
and control groups exhibited similar levels (Mann Whitney; U = 27, Z = -2.176, p = 
0.0296, Fig.6). Post hoc tests for the hippocampus revealed there was a significant 
difference between HSF and LSF groups (p < 0.05). All other comparisons were non-
significant.  
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Figure 6. SF induces increased IL-1β and TGF-β1 gene expression in the hypothalamus. 
SF also amplified TGF-β1 gene expression in the hippocampus.  Data are shown as mean 
± SE for each group. Gene expression was undetectable by RT-PCR in some tissues, 
which resulted in a decreased sample size in these groups. Shared letters indicate no 
significant difference between groups. Since the results are marginally significant for 
TGF-β1 gene expression in the prefrontal cortex, all bars share the same letters.  Numbers 
at the base of the column indicate sample size of the group.  
 
Sleep fragmentation increases serum corticosterone  
Serum corticosterone concentration varied significantly among treatments (Kruskal 
Wallis; H = 9.593; p = 0.0083, Fig.7). Mice exposed to HSF (248.88 ng/mL ± 17.14; 
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mean ± SE) had significantly increased serum corticosterone (Mann Whitney; U = 23; Z 
= -2.829; p = 0.0047, adjusted α = 0.017, Fig.7) when compared with controls (165.91 
ng/mL ± 14.72; mean ± SE).  There was also a trend for higher corticosterone levels in 
mice experiencing HSF compared with mice experiencing LSF (188.31 ng/ mL ± 
17.6033; mean ± SE) (Mann Whitney; U = 32; Z = -2.093; p = 0.0364; adjusted α = 
0.017, Fig.7).  Corticosterone concentration did not differ significantly between LSF and 
control mice (Mann Whitney; U = 44, Z = -1.354, p = 0.1757, Fig.7).  
 
 
Figure 7. Serum corticosterone concentrations increase following 24 hours of sleep 
fragmentation. Data are shown as mean (ng/ mL) ± SE for each group. Shared letters 
indicate there is no significant difference between groups. Numbers at the base of the 
column indicate sample size. 
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DISCUSSION 
It is widely accepted that sleep is an essential physiological process because acute 
and chronic sleep loss can lead to deleterious effects upon physiology and behavior (Nair 
et al., 2011; Simpson and Dinges, 2007; Zielinski et al., 2013). A previous study has 
suggested that sleep allows for metabolite clearance from the brain and cerebral spinal 
fluid (Xie et al., 2013). Consequently, curtailment of this cleansing period through sleep 
loss could potentially induce neuroinflammation towards a build-up of waste products. 
Current research holds that in addition to acting as modulators of inflammation, IL-1β 
and TNF-α act as sleep regulatory substances (SRS) that promote non-REM sleep after 
their release from glia in response to extracellular ATP (Jewett and Krueger, 2012). 
During periods of prolonged wakefulness, these cytokines accumulate in the brain and 
cerebral spinal fluid and are thought to be responsible for inducing symptoms of sleep 
loss, such as sleepiness, fatigue, and poor cognition, and enhanced sensitivity to pain 
(Clinton et al., 2011; Graves et al., 2003; Jewett and Krueger, 2012; Zielinski et al., 
2013). It is well known that sleep deprivation results in an acute inflammatory response, 
characterized by an increase in pro-inflammatory cytokines, such as IL-1β, TNF-α, IL-6, 
and an increase in serum glucocorticoids (Brager et al., 2013; Carreras et al., 2014; 
Hirotsu et al., 2012; Mullington et al., 2010; Simpson and Dinges, 2007; van Leeuwen et 
al., 2009).  The majority of studies investigating the effects of sleep loss on the immune 
system have completely deprived subjects of sleep. However, this model may not be 
applicable for patients suffering from disorders from incomplete sleep loss (multiple 
arousals per hour) because sleep homeostatic responses are likely different than those 
responding to complete deprivation (Ramesh et al., 2009).  Thus, it is highly likely that 
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the sleep fragmentation model used in this study more closely approximates these 
conditions.  
In this study, pro- and anti-inflammatory cytokine gene expression were 
upregulated following 24 hours of acute sleep fragmentation, with the response being 
heterogeneous in various tissue locations. More specifically, sleep fragmentation led to 
increased IL-1β gene expression in adipose tissue, heart (HSF only), and hypothalamus 
(LSF only), while gene expression of TGF-β1, an anti-inflammatory cytokine, was 
elevated in two out of three regions of the brain measured (hypothalamus and 
hippocampus) compared with non-sleep restricted controls. SF did not increase TNF-α 
gene expression in any of the tissues measured. Previous literature describes elevated 
TNF-α in sleep-restricted mice and rats, but because these studies assessed the effects of 
chronic sleep fragmentation, the results may not be directly comparable to an acute 
response (Ramesh et al., 2011; Venancio and Suchecki, 2014; Zhang et al., 2014). As a 
result, this study provides evidence that cytokine gene expression is altered following 
sleep fragmentation, and that the degree of sleep fragmentation has an impact upon the 
development of this inflammation.  Furthermore, based upon the cytokines selected for 
this experiment, the results suggest the induction of a pro-inflammatory environment in 
the periphery, and the production of a protective anti-inflammatory environment in the 
brain. The observed increases in cytokine gene expression in this experiment were 
detected at the mRNA level. Previous experimentation has shown that mRNA and protein 
expression levels of TNF-α are correlated following experimental sleep loss and vaccine 
stimulation. However, experiments involving IL-1β have produced conflicting results and 
TGF-β1 has not been studied within this context (Irwin et al., 2006; Shebl et al., 2010). 
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Consequently, it is equivocal whether protein levels correlate directly with mRNA 
expression, but nonetheless, increased mRNA expression still provides insight into the 
rapid temporal dynamics of cytokine activation at the transcriptional level. 
 
Table 1. The effect of 24 hours of sleep fragmentation on cytokine gene expression. 
Tissue Effect  
Liver  - 
Spleen - 
Fat  Increase: IL-1β 
Heart Increase: IL-1β 
Hypothalamus  Increase: IL-1β and TGF-β1  
Prefrontal Cortex - 
Hippocampus Increase: TGF-β1  
 
Chronic sleep fragmentation has been shown to increase orexigenic behavior, 
ultimately resulting in weight gain (Carreras et al., 2015; Wang et al., 2014). Since 
caloric expenditure does not change, and because glucose clearance and insulin 
sensitivity in adipocytes decrease with time following sleep restriction, the surplus 
calories become stored as fat (Wang et al., 2014; Zhang et al., 2014). Previous literature 
has indicated that although altered glucose homeostasis is present after 2 weeks of 
fragmented sleep, changes in body mass are absent (Carreras et al., 2014). Following a 
single night of sleep restriction, HSF mice lost significantly more body mass than LSF or 
control groups. In addition, serum corticosterone was elevated in HSF mice relative to 
other treatments. This result opposes previous studies indicating serum corticosterone 
levels that were similar between control and SF groups following 6 h of sleep 
fragmentation using the same type of sweeping bar apparatus (Ramesh et al., 2009). The 
discrepancy in corticosterone concentrations is likely due to a physiological stress 
response occurring in response to sleep loss for a 24 hour period. Alternatively, increases 
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in serum corticosterone concentration could have been attributed to a shift in natural 
biological rhythms from forced arousals during the light phase of the LD cycle or to an 
increase in activity levels in the SF groups as a result of tactile stimulation from the swipe 
bar. Pro-inflammatory cytokines peak during the rest period, typically during early slow 
wave sleep (Besedovsky et al., 2012). Because tissue is collected from the animals near 
the time in which sleep normally begins, it must be acknowledged that natural biological 
rhthyms could influence the observed results; however it is not likely. The combination 
of body mass loss and simultaneous increase in serum corticosterone concentrations 
imply that HSF mice were experiencing a physiological stress response, including 
activation of the HPA axis, as a result of sleep interruptions occurring so frequently.  It is 
unclear whether HPA activation occurred because of the method of sleep fragmentation 
used or the direct effect of disrupted sleep per se. Consequently, these data suggest that to 
minimize the effect of glucocorticosteroids on cytokine gene expression profiles 
following sleep fragmentation, the most effective model may be the LSF model (sleep 
interruptions every 2 minutes), as body mass loss and serum corticosterone 
concentrations were not different from those of controls. Since LSF mice exhibited 
altered adipose and hypothalamic cytokine gene expression relative to controls, this 
provides evidence that these results are not confounded by increased corticosterone 
levels, which can have immunoregulatory effects.  Use of the LSF model is in agreement 
with previous literature methodology of chronic SF experiments (Carreras et al., 2014; 
Carreras et al., 2015; Kaushal et al., 2012b; Ramesh et al., 2009; Zhang et al., 2014). 
Both the experimental time intervals of sleep fragmentation (HSF and LSF) were selected 
based upon the results of previous chronic studies (Ramesh et al., 2009; Ringgold et al., 
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2013). Due to altered cytokine gene expression and corticosterone concentrations in 
response to sleep fragmentation, it can be concluded that these time intervals are 
acceptable for eliciting an immune response using an acute model of sleep fragmentation.  
Not only has sleep loss been shown to have metabolic implications in human and 
mouse models, but it also results in cardiovascular alterations (Carreras et al., 2014; 
Kheirandish-Gozal et al., 2010; Zhang et al., 2014).  Shortened sleep intervals have been 
shown to increase the production of white blood cells, C - reactive protein, IL-6, and 
produce a simultaneous decrease in the anti-inflammatory cytokine IL-10, with the 
observed changes amplifying the risk for the development of future cardiovascular 
disease (Gozal et al., 2008; Kheirandish-Gozal et al., 2010; Mullington et al., 2009). 
Furthermore, chronic sleep fragmentation induces endothelial dysfunction and thickening 
and disruption of elastic fibers in the aortic arch and thoracic aorta (Carreras et al., 2014). 
Similar to these previous studies, even just 24 hours of sleep fragmentation leads to the 
inception of inflammation in organs that are susceptible to chronic inflammation in 
patients with obstructive sleep apnea (OSA), namely, in heart and adipose tissue 
(Carreras et al., 2014; Carreras et al., 2015; van Leeuwen et al., 2009).  IL-1β gene 
expression was upregulated in cardiac muscle tissue, indicating a pro-inflammatory 
environment that would be detrimental to surrounding tissue. After a period of chronic 
sleep loss, exposure to increasing levels of pro-inflammatory cytokines and accumulation 
of damage, likely due to oxidative stress produced by the NOX-2 enzyme found in 
macrophages during chronic inflammation, has the potential to lead to the onset of 
cardiovascular disease, but further investigation into this transition is needed (Carreras et 
al., 2014; Zhang et al., 2014). Previous literature also indicates the persistence of a pro-
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inflammatory environment following chronic sleep fragmentation due to a polarization 
towards the pro-inflammatory M1 macrophage subtype, ultimately resulting in a skew of 
the M1/M2 macrophage subtype ratio (Carreras et al., 2015; Zhang et al., 2014). Despite 
the acute nature of this experiment, a single 24 hour SF period was sufficient time to 
induce a pro-inflammatory environment in inguinal adipose tissue. Because acute sleep 
loss can lead to chronic effects over time, further investigation into this transition is 
needed to better understand the transition to pathology associated with chronic 
conditions, such as OSA. Additionally, future examination of epigenetic changes, such as 
changes in SIRT, may lead to a greater understanding of the progression from acute to 
chronic dysregulation of the immune system. 
While a pro-inflammatory response to sleep loss was observed in inguinal adipose 
and cardiac muscle tissue, an anti-inflammatory response was detected within the brain.  
This finding supports a previous study that indicates specifically within brain tissue, the 
anti-inflammatory environment and increased production of IL-10 could protect the brain 
against ischemic cell death preceding surgical procedures (Weil et al., 2009). Because a 
similar anti-inflammatory environment was observed in all regions of the brain in this 
experiment, with the upregulation of TGF-β1 gene expression following acute sleep 
fragmentation, this provides evidence for neuroprotection. Although there was an 
increase in IL-1β gene expression in the hypothalamus following sleep fragmentation, it 
could be explained by an accumulation of SRSs in the brain following a period of 
prolonged wakefulness and possibly the absence of metabolic clearance of the cerebral 
spinal fluid that takes place during sleep (Jewett and Krueger, 2012; Xie et al., 2013).  
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Consequently, further experimentation is needed to elucidate whether IL-1β is acting as 
an SRS or an inflammatory marker. 
  In conjunction with the rise in morbid obesity in recent years, obstructive sleep 
apnea (OSA) and other obesity-related sleep disorders are becoming more common. 
Sleep interruptions from these disorders influence overall restfulness from sleep and 
eventually lead to pathology over time due to chronic inflammation (Pulixi et al., 2014). 
While OSA is a chronic disease, understanding the acute effects of sleep fragmentation is 
essential, as it is these effects that eventually progress to chronic pathologies, such as 
cardiovascular and metabolic disease. This study reports a rapid inflammatory response 
in adipose and cardiac muscle tissue following a single 24 h period of interrupted sleep. 
Furthermore, pro-inflammatory gene expression increased as sleep became more 
fragmented. Because adipose and heart tissue are highly susceptible to dysfunction as a 
result of OSA, the acute elevation of pro-inflammatory cytokine gene expression in these 
tissue could provide an early indication of disease. Future studies are needed to fully 
characterize the acute inflammatory response to sleep loss, to understand its progression 
towards chronic pathology, and to identify epigenetic changes that may alter this 
acute/chronic transition. From a clinical standpoint, prophylactic measures could be 
developed to prevent the accumulation of inflammation and subsequent tissue 
dysfunction that OSA-related disorders create.  
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 CHAPTER 2: ACUTE SLEEP FRAGMENTATION INDUCES DIFFERENT 
CYTOKINE GENE EXPRESSION PROFILES IN OBESE AND LEAN MICE  
 
 
Obesity and sleep fragmentation are often times co-occurring pro-inflammatory 
conditions in patients with obstructive sleep apnea.  Despite the known association 
between the two, the simultaneous effects of the conditions on the immune and endocrine 
profiles have yet to be explored.  Consequently, we investigated changes in pro-
inflammatory (IL-1β, TNF-α) and anti-inflammatory (TGF-β1) cytokine gene expression 
in the periphery (liver, spleen, fat, and heart) and brain (hypothalamus, prefrontal cortex, 
and hippocampus) of lean and obese mice exposed to sleep fragmentation. Serum 
corticosterone concentration was also assessed. Sleep was disrupted in male C57BL/6J 
mice (lean) and ob/ob KO mice (obese) using an automated sleep fragmentation chamber. 
Trunk blood and tissue samples were collected after 24 h of SF. We predicted that the 
acute inflammatory response resulting from HSF would be different for the lean and the 
obese mice, with the highest cytokine gene expression levels being detected in the OB 
HSF group, due to a synergistic effect of the pro-inflammatory conditions.  While, 
obesity was found to be the factor that differentially affected cytokine gene expression 
profiles, the effect on cytokine gene expression varied from tissue to tissue. The pro-
inflammatory nature of both obesity and sleep loss was not found to be summative 
overall in this experimental model. Obesity significantly elevated cytokine gene 
expression in the hypothalamus (IL-1β and TNF-α), prefrontal cortex (IL-1β), 
hippocampus (IL-1β, TNF-α), liver (IL-1β, TGF- β1), and heart (TGF- β1). Conversely, 
decreases in pro-inflammatory cytokine gene expression were detected in the spleen (IL-
1 β), fat (IL-1β), and heart (IL-1β, TNF-α). Serum corticosterone concentration was 
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significantly elevated as a result of sleep fragmentation, with HSF mice exhibiting the 
highest serum corticosterone concentrations. These data indicate that obesity is a potent 
inducer of neuroinflamation, but leads to an anti-inflammatory response in the periphery, 
all within the context of elevated stress hormones. As a result, this suggests obese mice 
may have neuroendocrine adaptations to combat the pre-existing pro-inflammatory 
condition of obesity and that these adaptations may impact the acute inflammatory 
response to sleep loss.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
35 
INTRODUCTION 
In conjunction with the growing obesity epidemic in the United States, the 
number of individuals suffering from sleep disorders has continued to rise in recent years. 
It was estimated that in 2007, more than 40% of patients with sleep disordered breathing 
could be attributed to obesity (McNicholas et al., 2007). More specifically, Obstructive 
Sleep Apnea (OSA), a sleep disorder characterized by respiratory pauses during sleep, 
loud intermittent snoring and excessive daytime sleepiness, has risen steadily with the 
increased incidence of obesity (Ryan et al., 2009). In the general population, the 
prevalence of OSA is estimated to be between 5 and 10%; however, because often times 
OSA remains undiagnosed, this statistic is likely underestimated (Witkowski and 
Kadziela, 2015). The symptoms of OSA can be explained by repeated episodes of upper 
airway obstruction or collapse during sleep, resulting in increased respiratory efforts, 
periodic arterial oxygen desaturation, systemic and pulmonary arterial blood pressure 
increases and sleep disruption (McNicholas et al., 2007). Individuals suffering from 
severe sleep apnea can have up to thirty hypoxic attacks per hour, equating to sleep 
interruptions occurring every 2 minutes (Ramesh et al., 2009). While individuals 
suffering from OSA may or may not be fully aroused during these hypoxic events, the 
overall restfulness of sleep continues to be adversely affected, as sleep interruptions 
associated with OSA are known to decrease the amount of time spent in REM sleep 
(Ryan et al., 2009). Consequently, previous research has found that untreated OSA 
increases the risk for automobile accidents, worsens the quality of life and mood, 
decreases cognitive impairment, lessens productivity in the work place, and results in 
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daytime sleepiness (Akashiba et al., 2002; Finn et al., 1998; Hiestand et al., 2006; 
Schwartz et al., 2005; Teran-Santos et al., 1999). 
 Despite these detrimental effects of OSA, of even greater interest to physicians 
and researchers is the strong association between sleep interruptions and cardiovascular 
events. It has been found that untreated chronic OSA increases the risk for the 
development of hypertension, coronary vascular disease, congestive heart failure, 
cerebrovascular disease, glucose intolerance, impotence, stroke, and myocardial 
infarction (Hiestand et al., 2006; McNicholas et al., 2007).  When left untreated, severe 
OSA can be linked to an increased risk of mortality due to cardiovascular events. 
Consequently, the diagnosis and treatment of OSA have become a great health concern in 
an attempt to prevent the pathology associated with chronic exposure to the condition.  
The standard diagnostic technique for sleep apnea and other sleep disorders is 
overnight polysomnography in a sleep clinic (McNicholas et al., 2007; Ruehland et al., 
2009; Witkowski and Kadziela, 2015). Typically patients are recommended for a 
polysomnography study after a sleeping partner has complained of very loud snoring or 
gasping sounds during the night, coupled with the individual experiencing excessive 
daytime sleepiness (Ryan et al., 2009). However, a physician may also suggest a sleep 
study based upon the presence of additional risk factors indicative of future sleep 
disordered breathing, such as: a high arched palate, large tonsils, a long uvula, tongue 
indention, or abnormal posterior positioning of the maxilla or the mandible (Lee et al., 
2013). OSA is diagnosed when the apnea-hypopnea index (API) is greater than 15 events 
per hour during polysomnography (Witkowski and Kadziela, 2015). The apnea-hypopnea 
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index is a quantifiable measure of the severity of sleep apnea. In order to calculate the 
API, the number of stopped breathing events (apnea) and events in which the airflow 
through the abdominothoracic cavity is reduced (hypopnea) are counted and divided by 
the total number of hours spent sleeping (Ruehland et al., 2009). Taken together, apnea 
and hypopnea help to explain the increased respiratory efforts and oxygen desaturation 
typically observed with OSA.  
Once OSA has been diagnosed, the standard form of treatment is continuous 
positive airway pressure (CPAP) during sleep, which essentially acts as a splint to keep 
the upper airway open, thereby preventing the negative pressure during inspiration from 
building to facilitate the airway collapsing back on itself (McNicholas et al., 2007; Ryan 
et al., 2009). Previous research has shown that CPAP dramatically improves the overall 
well-being of individuals with OSA, as it normalizes their sleep pattern and helps better 
their day time alertness (Ryan et al., 2009). Additional studies have shown that 
adenotonsillectomy in non-obese children with OSA can reverse problematic 
physiological alterations, such as an increase in the pro-inflammatory cytokine IL-6, 
further highlighting the importance of seeking treatment for OSA to prevent the 
progression to cardiovascular disease and other complications (Gozal et al., 2008; 
Kardassis et al., 2013).     
 Helping to compound the potential dangers associated with untreated OSA is the 
fact that the incidence of OSA increases with the prevalence of obesity in a population 
(Hiestand et al., 2006).  In a U.S. population study for the National Sleep Foundation, it 
was found that 59% of obese individuals were at high risk for OSA (Shahar et al., 2001). 
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Furthermore, it has also been reported that OSA is commonly seen in morbidly obese 
patients, so much so that BMI has been used in scoring systems in order to predict OSA 
(O’Keeffe et al., 2004). Because both OSA and obesity have been demonstrated to 
independently impact inflammation and cardiac function, the summative effect of the two 
conditions is of particular concern. The association between obesity and OSA can be 
explained by physiological changes that occur as a direct consequence of increased 
adiposity. Firstly, the excess weight on the chest when lying in a supine position 
negatively effects respiratory efforts and may help facilitate the collapse of upper airways 
during sleep, ultimately increasing the frequency of hypoxic respiratory events 
(McNicholas et al., 2007). Additionally, other physiological alterations associated with 
obesity may contribute to negative cardiovascular outcomes as a result of OSA. Obesity 
is associated with left ventricle hypertrophy, pulmonary hypertension, and diastolic 
dysfunction, as a result of increased force being exerted on the heart (Otto et al., 2007). 
However, previous studies have shown that OSA also contributes to left ventricle 
hypertrophy and other changes associated with obesity, due to an increased degree of 
diastolic dysfunction observed in obese patients with OSA than those without (Arias et 
al., 2005; Otto et al., 2007). Consequently, changes in cardiovascular function and 
physiology attributed to obesity are exacerbated when concurrent with OSA, further 
underscoring the need to understand the progression towards pathology in both 
conditions. 
 Obesity is a low-grade pro-inflammatory condition, with adipose tissue exhibiting 
both paracrine and endocrine functions by releasing various hormones and cytokines into 
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the surrounding tissue and blood. Visceral adipose tissue releases a variety of pro and 
anti-inflammatory markers, namely: adipokines, leptin, adiponectin, resistin, IL-6, TNF-
α, monocyte chemoattractant protein-1 (MCP-1) (Kardassis et al., 2013; Ryan et al., 
2009). One proposed mechanism for the initiation of an inflammatory response 
associated with obesity is the disruption of tight junctions between adjacent intestinal 
epithelial cells; thereby allowing intestinal bacteria to escape into the periphery, and 
initiating an inflammatory response to the presence of bacterial LPS through TLR4 
(Teixeria et al., 2012). However, additional support for this proposed mechanism is still 
lacking. Obesity has also been associated with a greater polarization towards the M1 
macrophage subtype in adipose tissue, ultimately promoting the persistence of a pro-
inflammatory environment (Chawla et al., 2011). When compared to the adipose tissue of 
lean individuals, tissue from obese individuals shows an increase in molecules such as: 
TNF-α, IL-6, iNOS, TGF-β1, CRP, soluble ICAM and MCP-1, and the pro-coagulant 
protein plasminogen activator inhibitor type-1 (Weisberg et al., 2003).  Because of the 
persistent pro-inflammatory environment surrounding adipose tissue, obesity has been 
connected to conditions resulting from damage due to chronic inflammation, such as 
insulin resistance, diabetes, and cardiovascular disease (Ryan et al., 2009; Zhang et al., 
2014). Current hypotheses implicate oxidative stress as the causative factor for the 
development of insulin resistance, diabetes, and cardiovascular disease, due to cell and 
tissue damage following the prolonged pro-inflammatory response; however, a complete 
understanding of this mechanism is lacking (Khalyfa et al., 2014; Pak et al., 2014; Wang 
et al., 2014).        
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 In the same way that obesity induces a shift towards a pro-inflammatory 
phenotype, OSA also increases cytokine gene expression due to the sleep fragmentation 
caused by the condition. Previous literature indicates that sleep fragmentation increases 
corticosterone concentrations, leads to the upregulation of cell adhesion molecules on 
monocytes (ICAM-1, VCAM-1), and also increases the expression of inflammatory 
markers, such as CRP, TNF-α, IL-8, and IL-6 (Ciftci et al., 2004; Kent et al., 2011; Neto 
et al., 2010; Pak et al., 2014). It must be noted that increased expression of IL-6 and IL-8 
is particularly important in the progression towards cardiovascular disease following 
sleep fragmentation, as this leads to the release of CRP from the liver to upregulate the 
expression of cell adhesion molecules, and an increase in neutrophil and monocyte 
adhesion to the vascular endothelium, respectively (Murphy, 2012). The progression 
towards cardiovascular disease is facilitated by an increase in the expression of cell 
adhesion molecules and chemokines, allowing macrophages overwhelmed with oxidized 
lipids to be recruited to the vascular endothelium, where they become stuck, resulting in 
the development of an atherosclerotic cap in the vessel and subsequent structural changes 
in the elastic fibers of the vessel (Carreras et al., 2014; Ryan et al., 2009). The increase in 
pro-inflammatory cytokines due to OSA can be reduced following treatment with CPAP 
or adenotonsillectomy. Previous experiments have shown that adhesion molecules, such 
as ICAM-1 and VCAM-1, and cytokines, such as TNF-α, IL-6, and IL-10, return to 
normal values in human patients with OSA following treatment (Gozal et al., 2008; Ryan 
et al., 2009). Because both obesity and OSA are pro-inflammatory conditions associated 
with a simultaneous increase in the expression of cell adhesion molecules, both have the 
potential to enhance the rate of onset and severity of cardiovascular disease. 
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 Sleep interruptions attributable to OSA have been shown to have adverse 
metabolic consequences. Curtailment of the sleep period skews the balance between 
hunger and satiety hormone concentrations and alters normal feeding and activity 
behaviors, such that weight gain is the impending result. Previous literature indicates that 
concentrations of ghrelin, a hunger signaling hormone, and leptin and peptide YY, satiety 
signaling hormones, are altered following insufficient sleep (Garcia-Garcia et al., 2014). 
These changes are characterized by a decrease in serum concentrations of leptin, 
simultaneously occurring with an increase in ghrelin concentrations (Garcia-Garcia et al., 
2014). As a result, caloric intake increases in conjunction with surges in circulating 
ghrelin and simultaneous decreases in leptin and peptide YY concentrations (Garcia-
Garcia et al., 2014; Markwald et al., 2013; Mavanji et al., 2012). The elevated caloric 
intake can be explained by changes in the hormone concentrations in the hypothalamus. 
Under normal conditions, ghrelin binds to neurons expressing NPY and agouti-related 
peptide to send an orexigenic signal, while leptin binds to neurons expressing POMC and 
cocaine and amphetamine-related transcripts (CART) to produce an anorexigenic 
response (Garcia-Garcia et al., 2014). However, due to the changes in circulating 
hormone concentrations, the orexigenic response is activated over the anorexigenic 
response.  
The increase in food intake following sleep deprivation is thought to be in 
response to a rise in energetic demands due to prolonged wakefulness; however, because 
caloric expenditure does not change, the surplus calories become stored as fat (Markwald 
et al., 2013; Wang et al., 2014; Zhang et al., 2014). Further compounding the propensity 
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towards weight gain is the fact that sleep loss not only increases appetite, but also shifts 
an individual’s preference towards lipid-dense, high-calorie food. This response provides 
more opportunity to eat while awake, and results in decreased amounts of physical 
activity as a result of sleepiness and fatigue (Garcia-Garcia et al., 2014).  It must be noted 
that while the increase in food intake leads to weight gain for in chronic sleep 
fragmentation studies, previous experiments have also reported that rodents experience a 
decrease in weight following prolonged wakefulness, indicating the experimental time 
period may have some effect on this observation (Baud et al., 2013; Hakim et al., 2012; 
Venancio and Suchecki, 2014).  One such experiment indicates that chronic sleep 
fragmentation must exceed 2 weeks in order for increases in body weight to be present 
(Carreras et al., 2014).  
Further investigations into the metabolic changes associated with sleep 
fragmentation have postulated a relationship between obesity, inflammation, and the 
development of insulin resistance and reduced glucose clearance. Chronic sleep 
fragmentation results in a reduction in insulin sensitivity and glucose clearance in adipose 
tissue (Carreras et al., 2015; Zhang et al., 2014). Previous literature has implicated two 
different proposed mechanisms of oxidative stress for the development of insulin 
insensitivity and reduced glucose tolerance as a consequence of the accumulation of 
tissue damage (Mesarwi et al., 2015). One such mechanism proposes superoxide and 
reactive oxygen species generated by the nicotinamide adenine dinucleotide phosphate 
oxidase-2 (NOX-2) enzyme in macrophages are the causative agents of tissue damage 
and inflammation, ultimately accounting for adipose tissue insulin resistance previously 
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described (Zhang et al., 2014). Because the activity of the NOX-2 enzyme increases with 
the duration of exposure to sleep fragmentation, the damage due to oxidative stress 
results in glucose intolerance and reduced insulin sensitivity with the passage of time 
(Zhang et al., 2014). Helping to support this mechanism is the fact that additional 
experimentation revealed NOX-2 activity was required for increased adiposity and 
subsequent weight gain in mice following 3 weeks of chronic sleep loss (Khalyfa et al., 
2014).  As a result, over time, the metabolic changes in adipose tissue associated with 
sleep fragmentation explain the development of diabetes, hypertension, and other 
conditions associated with chronic exposure to the condition.   
However, another proposed mechanism involves endoplasmic reticulum (ER) 
stress due to ROS from cholesterol and free fatty acids or calcium depletion from the 
sarcoplasmic reticulum (Lee and Ozcan, 2014). In this mechanism, ER stress leads to an 
unfolded protein response. The unfolded protein response results in upregulated 
expression of protein folding machinery to try to catch up, which then causes suppressed 
leptin signaling in the hypothalamus, to bring about an increase in caloric intake (Hakim 
et al., 2015; Lee and Ozcan, 2014). In support of this mechanism, additional 
experimentation detected an increase in PTP1B activation (phospho-tyrosine protein 
kinase that negatively regulates insulin signaling) following ER stress in the 
hypothalamus, resulting in attenuation of leptin receptor signaling (Hakim et al., 2012). 
The attenuation of leptin receptor signaling provides an additional explanation for the 
development of obesity and metabolic dysfunction (Hakim et al., 2015).  Consequently 
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this suggests, leptin also plays a major role in the progression towards insulin resistance 
and cardiovascular mortality associated with OSA (Fu et al, 2015).   
Leptin, resistin, and adiponectin are adipokines secreted by adipose tissue that are 
essential in regulating metabolic functions, such as insulin sensitivity and glucose 
tolerance (Fu et al., 2015). While leptin is a peptide hormone that is produced by adipose 
tissue and circulates to the hypothalamus to act as a satiety hormone, resistin and 
adiponectin regulate insulin sensitivity (O’Donnell et al., 2000). Serum leptin levels are 
directly related to adipose tissue mass, meaning increased leptin levels are associated 
with obesity (Al Maskari and Alnaqdy, 2006).  Although obesity is associated with an 
increased concentration of leptin, there is no corresponding loss of appetite, which 
suggests that leptin resistance is occurring (O’Donnell et al., 2000). In addition to having 
metabolic functions, leptin is also implicated as a potential player in regulation of the 
sleep wake cycle, since leptin deficient mice exhibit altered sleep architecture.  Leptin 
deficiency results in more frequent, shorter-duration sleep periods, increased bouts of 
REM sleep, and decreased recovery to sleep deprivation (Laposky et al., 2006). 
Furthermore, leptin is a pro-inflammatory signal that supports immune cell activation, 
proliferation, differentiation and the production of pro-inflammatory cytokines, such as 
IL-1, IL-12, TNFα and Th1 cytokines like IFN-γ (Besedovsky et al., 2012).  
Due to alterations in leptin concentrations following sleep fragmentation in OSA, 
it has been hypothesized that leptin can be used as a biomarker to detect the presence of 
sleep disorders (Ozturk et al., 2003; Pan and Kastin, 2014). Despite this predicted 
relationship, previous attempts have yet to successfully correlate leptin and leptin gene 
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receptor polymorphisms with OSA (Lv et al., 2015). In lieu of this failed attempt, other 
previous experiments have shown leptin concentrations are affected by sleep 
fragmentation; although the conflicting results have been reported as to if the alteration is 
an increase or a decrease (Fu et al., 2015; Garcia-Garcia et al., 2014; Ozturk et al., 2003). 
Consequently, leptin concentrations are also affected by both sleep fragmentation and 
obesity.  
Because OSA and obesity are often times comorbid, we wanted to determine if 
the pre-existing pro-inflammatory environment associated with obesity influences the 
acute inflammatory response as a result of sleep loss. While pathologies associated with 
OSA are due to chronic exposure to the condition, we chose to investigate an acute model 
of sleep fragmentation because acute effects may become chronic effects over time. Since 
little is understood about the acute effects of sleep fragmentation and the progression 
towards chronic disease, we chose to begin to characterize this model. In order to do this, 
the effects of acute sleep fragmentation on pro-inflammatory (IL-1β and TNF-α) and 
anti-inflammatory (TGF-β1) cytokine gene expression in brain and peripheral tissue of 
lean and obese mice were investigated. Serum corticosterone concentrations were also 
quantified. The ob/ob knock-out (KO) mouse lacking the leptin gene was chosen as the 
model organism of obesity for this experiment. The ob/ob KO mouse exhibits 
hyperphagia, hyperinsulinemia, hypercorticosteronemia, and sterility as a result of 
genetic modification, but previous experimentation demonstrated impaired respiratory 
mechanisms during sleep in this strain, similar to those observed in patients with OSA 
(Jackson Laboratory website; O’Donnell et al., 2000).  
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While investigations into the immune and endocrine reaction surrounding the 
interplay of acute sleep fragmentation and obesity are still lacking, previous literature 
revealed a difference in the effects of sleep fragmentation on neurobehavior (sensitivity 
to pain, diet, and anxiety) in lean mice and obese mice (pan-leptin receptor KO) (He et 
al., 2015). As a result of this experiment, we hypothesized that the response to high sleep 
fragmentation (HSF) would be different between lean and obese mice. Based upon 
previous literature, it was hypothesized that this difference could go one of two ways. 
Firstly, the effects of HSF on inflammation could be attenuated in the obese animals as a 
result of pre-existing neuroendocrine adaptations intended to minimize the effects of 
chronic low-grade inflammation associated with obesity (He et al., 2015; Pak et al., 
2014). More specifically if this were the case, we would expect that serum corticosterone 
levels and the gene expression of cytokines (IL-1β, TNF-α, TGF- β1) characterizing the 
inflammatory response in the brain and periphery of the obese mouse would be lower 
than that of the lean mouse. We predicted that the highest cytokine gene expression 
values and serum corticosterone concentrations would be observed in the lean HSF 
group. However, an alternative hypothesis could be because both obesity and sleep 
fragmentation are pro-inflammatory conditions, the effects on the inflammatory response 
would be summative. Consequently, if this were the case, we would expect an increase in 
cytokine gene expression (IL-1β, TNF-α, TGF- β1) in the brain and periphery and an 
increase in serum corticosterone concentrations in the obese mice compared to the lean 
group, with the highest values seen in the obese HSF group.  
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METHODS AND MATERIALS 
 
Animals  
Male C57BL/6J mice (n = 16) and male ob/ob leptin gene knockout mice  (n = 18) were 
housed in a colony room (12 h light/ 12 h dark, lights on 07:00 h; 21°C ± 1°C) at Western 
Kentucky University. To obtain the ob/ob knockout mice, Jackson Laboratory OB 
heterozygotes were purchased to form breeding trios. Ob/ob homozygous recessive 
offspring lacking the leptin gene were identified phenotypically by weight around 4 
weeks of age. After weaning at 21 d of age, mice resided in polypropylene cages with 
same sex littermates and were provided corncob bedding, as well as food, and water ad 
libitum. This study was conducted under approval of the Institutional Animal Care 
Committee at Western Kentucky University and procedures followed the National 
Institutes of Health Guide for the Use and Care of Laboratory Animals and international 
ethical standards. 
 
Sleep fragmentation 
Male adult ( > 8 weeks of age) ob/ob mice and C57BL6/J mice were selected for 
experimentation and were briefly exposed to isoflurane vapors and weighed to the nearest 
0.01 g. C57BL6/J mice ranged in age from 23 weeks – 31 weeks of age. Ob/ob mice 
ranged from 8 – 10 weeks of age. Two to four mice were then placed in an automated 
sleep fragmentation chamber (Lafayette Industries, Lafayette, IN; Model 80391) with a 
thin layer of corn cob bedding at 09:00 h. Previously it has been demonstrated that 
because mice are social animals, isolation during sleep deprivation induces differential 
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effects for socially isolated and paired animals (Kaushal et al., 2012a). As a result, the 
number of animals in the cage does not affect the resulting inflammatory response, it is 
only necessary that the animals remain in a social environment and not in isolation. Food 
and water were provided ad libitum. To distinguish among subjects, tails were marked 
with a different colored pen (Sharpie). At 8:00 the next day, the swipe bar was activated 
according to the previously described experimental protocol. Based upon the result of 
previous experiments, the “high” sleep fragmentation (HSF) interval was chosen to 
represent the sleep fragmentation group and the swipe bar interval was set to 20 seconds 
(Ramesh et al., 2009). For the control group, the bar remained stationary. Thirty-four 
mice were randomly assigned to either control (n = 8), HSF (n = 8), obese (OB) control 
(n = 9), or obese (OB) HSF groups (n = 9). To minimize the number of animals 
sacrificed, frozen tissue collected from 8 male C57BL6/J during the first experiment was 
selected for use for the control and HSF groups for this experiment. RNA was extracted 
from the tissue samples, reverse transcription was performed, and the resulting cDNA 
was used for RT-PCR analysis. All frozen tissue samples (liver, spleen, fat, heart, 
hypothalamus, prefrontal cortex, and hippocampus) came from the same randmomly 
selected individual.  
 
After HSF or control conditions for 24 h, the obese animals were deeply anesthetized 
using isoflurane vapors (< 2 min), weighed, and then rapidly decapitated within 3 min of 
initial handling. Trunk blood was collected, kept on ice for < 20 min, and then spun at 
3000 x g for 30 minutes at 4°C. The serum was drawn off and stored at -80°C for later 
ELISA analysis.  Liver, spleen, inguinal fat, and heart samples were collected and placed 
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into Eppendorf tubes containing RNAlater solution (Life Technologies). The tissue 
samples were stored at 4°C until RNA extraction was performed. The hypothalamus, 
prefrontal cortex, and hippocampus were then dissected from the brain and stored in 
RNAlater at -20°C until RNA extraction. 
 
RNA Extraction  
RNA was extracted from brain, liver, spleen, and fat using an RNeasy Mini Kit (Qiagen). 
RNA was extracted from the heart using an RNeasy Fibrous Tissue Mini Kit. RNA 
concentration was measured using a NanoDrop 2000 Spectrophotometer (Thermo 
Scientific). 
 
Reverse Transcription  
Total RNA was reverse transcribed into cDNA using a High-Capacity cDNA Reverse 
Transcription kit (Life Technologies, #4368813). The total RNA concentration of the 
tissue was diluted (brain: 9.2; liver, spleen, and fat: 10.8 ng/µL; heart: 21.9 ng/µL). The 
reaction was carried out according to the manufacturer’s instructions. The amplification 
conditions for the thermocycler were 25°C for 10 min, 37°C for 120 min, 85°C for 5 min 
(for 1 cycle), and then 4°C .   
 
RT-PCR 
Real Time- PCR was performed using an ABI 7300 RT-PCR System. To determine 
relative cytokine gene expression, Taqman Gene Expression RT-PCR Master Mix and 
the following primer/probes (Applied Biosystems) were used: IL-1β (Mm00434228_m1), 
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TNF-α (Mm00443260_g1), and TGF-β (Mm01178820_m1), or 18s endogenous primer-
limited (Mm03928990_g1). Cytokine probes were labeled with the fluorescent marker 5-
FAM at the 5’ end and the quencher MGB at the 3’ end. The 18s endogenous control 
used a VIC-labeled probe. The amplification conditions were 50°C for 2 min, 95°C for 
10 min, 40 cycles of 95°C for 15 seconds, and 60°C for 1 min.  The reaction was carried 
out according to the manufacturer’s instructions, and allowed for the determination of the 
relative expression of IL-1β, TNF-α, and TGF-β by comparison with the standard curve 
generated using serial dilutions of pooled cDNA (1:1, 1:10, 1:100, 1:1000, 1:10000) and 
normalization to the control 18s ribosomal RNA levels. 
 
ELISA  
Serum corticosterone concentration was determined using an ELISA kit (ab108821; 
Abcam) with 96% recovery for corticosterone (0.3 ng/mL sensitivity). The reagents and 
standards were prepared according to the manufacturer’s instructions. Cross reactivities 
for the kit were < 30% deoxycorticosterone, < 2% aldosterone, < 2% progesterone, and < 
1% cortexolone.  Serum samples were diluted 1:200 per the manufacturer’s instructions 
and plated in duplicate. The reaction was carried out according to the kit instructions and 
the average absorbance of the plate was determined using a plate reader and subtracting 
the absorbance at 450 nm from the absorbance at 570 nm per the manufacturer’s 
instructions (BioTek Synergy H1 Hybrid Reader). Corticosterone concentrations were 
extrapolated from a standard curve using a log transformed-log transfomed curve fit 
(Excel) and multiplying by the dilution factor (1:200). The intraassay variation was 5.0% 
CV.   
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 Statistical Analyses  
All data are expressed as mean ± standard error (SE). Two-way ANOVAs were used to 
detect differences among groups, with sleep treatment (control (no SF) vs. HSF), 
genotype (wildtype vs. ob/ob), and the interaction between two as the main factors, and 
relative gene expression of each specific cytokine as the dependent variable. Post hoc 
tests were carried out using a Fisher’s LSD test, using a one-way ANOVA to determine 
the significant interactions. In some cases, logarithmic transformation was necessary to 
satisfy requirement of homogeneity of variances. Statistical analyses were carried out 
using SPSS and Statview programs. 
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RESULTS 
Highly fragmented sleep results in body mass loss 
Body mass significantly decreased following 24 hours of SF (two-way ANOVA; F1,30 = 
41.101, p < 0.0001; Fig.8). Post-hoc tests revealed that body mass loss was significantly 
different between the control (-0.85 g ± 0.71 g; mean ± SE) and HSF (-2.69 g ± 1.30 g; 
mean ± SE) groups (p < 0.05, Fig.8) and between the OB control (-0.68 g ± 0.44 g; mean 
± SE) and OB HSF groups (-2.49 g ± 0.68 g; mean ± SE) groups (p < 0.05, Fig.8). 
Additionally, there were differences between the control and OB HSF group and between 
the HSF group and the OB control (p < 0.05, Fig.8).  However, there were no significant 
differences in body mass loss due to obesity (two-way ANOVA; F1,30 = 0.414; p = 
0.5347; Fig.8) or the interaction between sleep and obesity (two-way ANOVA; F2,30  = 
0.003; p = 0.9563; Fig.8).  
 
Obesity increases cytokine gene expression in the liver   
Obesity increased TNF-α gene expression in liver tissue relative to controls (two-way 
ANOVA; log-transformed; F1,25 = 6.748, p = 0.0155; Fig.9). Post-hoc tests revealed that 
TNF-α gene expression was different between the wildtype control and OB control 
groups (p = 0.0096, Fig. 9) and between the control and OB HSF groups (p = 0.0073, Fig. 
9). In contrast, sleep (two-way ANOVA; log-transformed; F1,25 = 2.076; p = 0.1620; 
Fig.9) and the interaction between the two factors (two-way ANOVA; log-transformed; 
F2,25 = 1.330; p = 0.2597; Fig.9) did not alter TNF-α gene expression in the liver. Obesity 
also increased TGF-β1 gene expression in the liver (two-way ANOVA; log-transformed; 
F1,28 = 12.352, p = 0.0015; Fig.9). Post-hoc tests showed that TGF-β1 gene expression 
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was different between both the control and OB control group (p = 0.0038; Fig.9) and the 
control and OB HSF group (p = 0.0027; Fig.9). No other factors affected TGF-β1 gene 
expression in the liver (two-way ANOVA; log-transformed; sleep: F1,28 = 1.257; p = 
0.2717; interaction: F2,28 = 0.646; p = 0.4282; Fig.9). There were no significant 
differences in IL-1β gene expression in the liver (two-way ANOVA; log-transformed; 
sleep: F1,27 =0.809; p = 0.3765; obesity: F1,27 =2.875; p = 0.1015; interaction: F2,27 = 
0.993; p = 0.3280; Fig.9). 
 
Figure 8. HSF induces changes in body mass in both obese and lean mice after 24 hours. 
Data are shown as mean body mass lost (g) ± SE for each group. Shared letters indicate 
no significant difference between groups.  The numbers at the base of the column 
indicate the sample size of each group. 
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Obesity decreases IL-1β gene expression in the spleen   
IL-1β gene expression was significantly decreased in the spleen due to obesity (two-way 
ANOVA; log-transformed; sleep: F1,26 = 6.391; p = 0.0179; Fig.9). Post-hoc tests 
revealed that the difference in splenic IL-1β gene expression was between the HSF and 
OB HSF groups (p = 0.0153: Fig.9). Conversely, there was no effect due to sleep or the 
interaction between the two factors (sleep: F1,26 =0.154; p = 0.6978; interaction: F2,26 = 
0.1.233; p = 0.2769; Fig.9). Similarly, there were no significant differences in TNF-α 
gene expression detected in the spleen due to any of the factors tested (two-way 
ANOVA; log-transformed; sleep: F1,28 =0.022; p = 0.8834; obesity: F1,28 =0.071; p = 
0.7920; interaction: F2,28 = 0.292; p = 0.5935; Fig.9). 
 
Highly fragmented sleep increases TGF-β1 expression in the spleen 
Highly fragmented sleep increased TGF-β1gene expression in the spleen (two-way 
ANOVA; log-transformed; F1,25 = 6.821, p = 0.0150; Fig.9). Post-hoc tests revealed a 
significant increase in splenic TGF-β1 gene expression between the control and HSF 
group (p = 0.0155; Fig.9), between the control and OB control (p = 0.0320; Fig.9), and 
between the control and OB HSF group (p = 0.0049; Fig.9). However, no other factors 
affected TGF-β1 gene expression in the spleen (two-way ANOVA; log-transformed; 
obesity: F1,25= 3.278, p = 0.0823; interaction: F2,25 = 1.857, p = 0.1851; Fig.9).  
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Obesity and the interaction between sleep and obesity affect pro-inflammatory 
cytokine gene expression in inguinal adipose tissue  
IL-1β gene expression was significantly different in the inguinal adipose tissue due to 
obesity (two-way ANOVA; log-transformed; F1,26 = 6.391; p = 0.0179; Fig.9) and the 
interaction between sleep and obesity (two-way ANOVA; log-transformed; F2,26 = 4.627; 
p = 0.0403; Fig.9). Post-hoc analysis indicated a decrease in IL-1β gene expression due 
to obesity between the HSF and OB control (p = 0.0403; Fig.9). Additionally, the 
difference due to an interaction between sleep and obesity was also a decrease between 
the HSF and OB HSF groups (p = 0.0035; Fig.9). Furthermore, sleep did not affect IL-1β 
gene expression in inguinal adipose tissue (two-way ANOVA; log-transformed; sleep: 
F1,26 = 0.304; p = 0.5859; Fig.9 ). TNF-α gene expression was significantly altered in the 
inguinal adipose tissue due to the interaction between sleep and obesity (two-way 
ANOVA; log-transformed; F2,28 =8.886; p = 0.0059; Fig.9). Post-hoc analysis revealed 
that TNF-α gene expression was significantly increased in inguinal adipose tissue 
between the control and HSF group due to sleep (P = 0.0015; Fig.9), while TNF-α gene 
expression was decreased due to obesity between the HSF and OB HSF groups (P = 
0.0275; Fig.9). No other factors affected TNF-α gene expression in the inguinal adipose 
tissue (two-way ANOVA; log-transformed; sleep: F1,28 =3.963; p = 0.0564; obesity: F1,28 
= 0.095; p = 0.0.7596; Fig.9).  Similarly, none of the factors tested affected TGF-β1 gene 
expression in inguinal adipose tissue (two-way ANOVA; sleep: F1,28 = 0.002, p = 0.9623; 
obesity: F1,28  = 0.037, p = 0.8485; interaction: F2,28  = 0.011, p = 0.9175; Fig.9). 
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Figure 9. Effects of fragmented sleep, obesity, and the interaction between the two factors 
on cytokine gene expression in the liver, spleen, and inguinal adipose tissue. Data are 
shown as mean ± SE for each group. Gene expression was undetectable by RT-PCR in 
some tissue samples, resulting in a decreased sample size in these groups.  Shared 
symbols indicate no significant differences between groups. Column capitalization 
corresponds with the groups being compared.  The numbers at the base of the column 
indicate the sample size of the group. 
 
Cytokine gene expression in cardiac muscle tissue is different for lean and obese 
mice  
Obesity decreased IL-1β gene expression in cardiac muscle tissue (two-way ANOVA; 
log-transformed, F1,29 = 50.719; p < 0.001; Fig.10). Post-hoc analysis revealed   
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differences between the control and OB control groups (p = 0.0005; Fig. 10), between the 
control and OB HSF groups (p < 0.0001; Fig. 10), between the HSF and OB control 
group (p < 0.0001; Fig. 10), and between the HSF and OB HSF groups (p < 0.0001; Fig. 
10). No other factors affected IL-1βgene expression (two-way ANOVA; log-transformed: 
sleep: F1,29 = 0.003, p = 0.9555; interaction: F2,29 = 2.876, p = 0.1006; Fig.10). 
Additionally, both highly fragmented sleep (two-way ANOVA; log-transformed, F1,29 = 
16.106, p = 0.0004; Fig.10) and obesity (two-way ANOVA; log-transformed, F1,29 = 
28.964, p < 0.001; Fig.10) decreased TNF- α gene expression in the heart, but there was 
no interaction between the two factors (two-way ANOVA; log-transformed, F2,29 = 
1.660, p = 0.2078; Fig.10)  Post-hoc analysis indicated that there was significant 
difference between the control and OB control groups (p = 0.0064, Fig.10), between the 
control and OB HSF group (p < 0.0001; Fig. 10), between the HSF and OB HSF groups 
(p < 0.0001, Fig.10), and between the OB control and OB HSF group (p < 0.0001; Fig. 
10). Furthermore, a significant increase in TGF-β1 gene expression was detected in 
cardiac muscle tissue due to obesity (two-way ANOVA; F1,29 = 77.344, p < 0.001; 
Fig.11). Post-hoc analysis revealed differences in TGF-β1 gene expression in cardiac 
muscle between both the control and OB control groups (p < 0.0001; Fig. 11), between 
the control and OB HSF group (p < 0.0001; Fig. 11 ), between the HSF and OB control 
(p < 0.0001; Fig. 11), and between the HSF and OB HSF groups (p < 0.0001; Fig.11). 
There were no differences in TGF-β1 gene expression due to any of the other factors 
(two-way ANOVA; sleep: F1,29 = 3.275, p = 0.0807; interaction: F2,29 = 1.014, p = 
0.3223; Fig.11). 
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Figure 10. Obesity decreases pro-inflammatory cytokine gene expression profile in 
cardiac muscle tissue. Data are shown as mean ± SE for each group. Shared symbols 
indicate no significant differences between groups. Column capitalization corresponds 
with the groups being compared.  The numbers at the base of the column indicate the 
sample size of the group. 
 
Obesity increases pro-inflammatory cytokine gene expression in the hypothalamus  
IL-1β gene expression was significantly elevated in the hypothalamus due to obesity 
(two-way ANOVA; log-transformed; F1,26 = 11.637, p = 0.0021; Fig.12). Post-hoc tests 
revealed that IL-1β gene expression was different between control and OB control groups 
(p = 0.0195, Fig. 12), between the control and OB HSF group (p = 0.0177, Fig.12), 
between the HSF and OB control (p = 0.0296, Fig.12) and between the HSF and OB HSF 
groups (p = 0.0275, Fig.12). However, no other factors affected IL-1β gene expression in 
the hypothalamus (two-way ANOVA; log-transformed, sleep: F1,26 = 0.002, p = 0.9619; 
interaction: F2,26 = 0.012, p = 0.9138; Fig.12). Additionally, obesity increased TNF-α 
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gene expression in the hypothalamus (two-way ANOVA; log-transformed, F1,25 = 
29.267, p < 0.0001; Fig.12). Post-hoc analysis revealed significant differences between 
the control and OB control (p = 0.0038; Fig.12), between the control and OB HSF group 
(p = 0.0035; Fig.12), between the HSF group and the OB control (p = 0.0002; Fig.12), 
and between the HSF and OB HSF groups (p < 0.0001; Fig.12). However, no other 
factors affected TNF-α gene expression in the hypothalamus (two-way ANOVA; log-
transformed; sleep: F2,25 = 1.196, p = 0.2845; interaction: F1.25 = 0.655, p = 0.4260; 
Fig.12). Additionally, there were no significant differences in TGF-β1 gene expression in 
the hypothalamus due to any of the factors tested (two-way ANOVA; log-transformed; 
sleep: F1,25 = 2.294; p = 0.1424; obesity: F1,25 = 0.035; p = 0.8541; interaction: F2,25 = 
0.214; p = 0.6474; Fig.12).  
 
Figure 11. Obesity increases anti- inflammatory cytokine gene expression profile in 
cardiac muscle tissue. Data are shown as mean ± SE for each group. Shared symbols 
indicate no significant differences between groups. The numbers at the base of the 
column indicate the sample size of the group. 
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Obesity increases pro-inflammatory cytokine gene expression in the hypothalamus  
IL-1β gene expression was significantly elevated in the hypothalamus due to obesity 
(two-way ANOVA; log-transformed; F1,26 = 11.637, p = 0.0021; Fig.12). Post-hoc tests 
revealed that IL-1β gene expression was different between control and OB control groups 
(p = 0.0195, Fig.12), between the control and OB HSF group (p = 0.0177, Fig.12), 
between the HSF and OB control (p = 0.0296, Fig.12) and between the HSF and OB HSF 
groups (p = 0.0275, Fig.12). However, obesity was the only factor affecting this increase 
(two-way ANOVA; log-transformed, sleep: F1,26 = 0.002, p = 0.9619; interaction: F2,26 = 
0.012, p = 0.9138; Fig.12). Additionally, obesity increased TNF-α gene expression in the 
hypothalamus (two-way ANOVA; log-transformed, F1,25 = 29.267, p < 0.0001; Fig.12). 
Post-hoc analysis revealed significant differences between the control and OB control (p 
= 0.0038; Fig.12), between the control and OB HSF group (p = 0.0035; Fig.12), between 
the HSF group and the OB control (p = 0.0002; Fig.12), and between the HSF and OB 
HSF groups (p < 0.0001; Fig.12). However, sleep and the interaction between sleep and 
obesity did not affect the changes TNF-α gene expression in the hypothalamus (two-way 
ANOVA; log-transformed; sleep: F2,25 = 1.196, p = 0.2845; interaction: F1.25 = 0.655, p = 
0.4260; Fig.12). Furthermore, there were no significant differences in TGF-β1 gene 
expression in the hypothalamus for any of the factors tested (two-way ANOVA; log-
transformed; sleep: F1,25 = 2.294; p = 0.1424; obesity: F1,25 = 0.035; p = 0.8541; 
interaction: F2,25 = 0.214; p = 0.6474; Fig.12). 
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Obesity increases IL-1β gene expression in the prefrontal cortex 
IL-1β gene expression was significantly elevated in the prefrontal cortex as a result of 
obesity (two-way ANOVA; log-transformed; obesity: F1,27 = 6.899; p = 0.0140; Fig.12). 
Post-hoc tests indicated that the difference was between the control and OB control (p = 
0.0.0372; Fig.12) and between the control and OB HSF group (p = 0.0108; Fig.12). 
However, no other factors affected IL-1β gene expression (two-way ANOVA; log- 
transformed; sleep: F1,27 = 1.432; p = 0.2419; interaction: F2,27  = 0.264; p = 0.6115; 
Fig.12).  Additionally, there were no significant changes in TNF-α gene expression (two-
way ANOVA; log-transformed; sleep: F1,27 =0.319; p = 0.5769; obesity: F1,27 = 0.225 ; p 
= 0.6394; interaction: F2,27 = 0.118; p = 0.7340; Fig.12) or TGF-β1 gene expression 
(two-way ANOVA; sleep: F1,28 =0.006; p = 0.9388; obesity: F1,28  =0.066; p = 0.7985; 
interaction: F2,28  = 1.276; p = 0.2682; Fig.12) for any of the factors tested in the 
prefrontal cortex.  
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Figure 12. Obesity increases pro-inflammatory cytokine gene expression in the brain. 
Data are shown as mean ± SE for each group. Gene expression was undetectable by RT-
PCR in some tissues, which resulted in a decreased sample size in these groups. Shared 
symbols indicate no significant differences between groups. Column capitalization 
corresponds with the groups being compared.  The numbers at the base of the column 
indicate the sample size of the group. 
 
Obesity increases pro-inflammatory cytokine gene expression in the hippocampus 
Obesity increased IL-1β gene expression in the hippocampus (two-way ANOVA; log-
transformed, F1,28 = 9.876, p = 0.0039; Fig.12). Post-hoc tests revealed the difference was 
between the control and OB control (p = 0.0182; Fig.12) and between the control and OB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b 
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HSF group (p = 0.00281; Fig.12). However, no other factors affected IL-1β gene 
expression in the hippocampus (two-way ANOVA; log-transformed, sleep: F1,28  = 2.218, 
p = 0.0.1476; interaction: F2,28  = 0.165, p = 0.6880; Fig.12). Additionally, obesity 
increased TNF-α gene expression in the hippocampus (two-way ANOVA; log-
transformed, F1,29 = 24.539, p < 0.0001; Fig.12). Post-hoc analysis revealed significant 
differences between the control and OB HSF group (p = 0.0019; Fig.12), between the 
HSF and OB control (p = 0.0012; Fig.12), and between the HSF and OB HSF groups (p < 
0.0001; Fig.12). However, no other factors affect TNF-α gene expression in the 
hippocampus (two-way ANOVA; log-transformed; sleep: F1,29  = 0.001, p = 0.9799; 
interaction: F2,29  = 4.123, p = 0.0516; Fig.12). Similarly, there was no significant 
difference in TGF-β1 gene expression in the hippocampus due to any of the factors (two-
way ANOVA; sleep: F1,27 =0.074; p = 0.7873; obesity: F1,27  =0.127; p = 0.7240; 
interaction: F2,27  = 1.116; p = 0.3002; Fig.12). 
 
Sleep fragmentation increases serum corticosterone  
Serum corticosterone concentration varied significantly among treatments due to sleep 
(two-way ANOVA; F1,30 = 41.101; p < 0.0001; Fig.13). Post-hoc tests revealed that lean 
mice exposed to HSF (200.58 ng/mL ± 30.02; mean ± SE) had significantly increased 
serum corticosterone (p = 0.0310, Fig.13) when compared with control mice (112.36 
ng/mL ± 16.89; mean ± SE).  Additionally, the OB HSF mice had significantly higher 
serum corticosterone concentrations than the lean control mice (p = 0.0083, Fig.13) and 
also higher levels than the OB control mice (140.71 ng/mL ± 20.65; mean ± SE) (p = 
0.0404, Fig.13). However, serum corticosterone concentration did not differ significantly 
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due to obesity (two-way ANOVA; F1,30 = 0.777; p = 0.3850; Fig.13) or as a result of the 
interaction between sleep and obesity (two-way ANOVA; F2,30 = 0.031; p = 0.8609; 
Fig.13).  
  
 
Figure 13. Serum corticosterone concentrations increase following 24 hours of sleep 
fragmentation in both lean and obese mice. Data are shown as mean (ng/ mL) ± SE for 
each group. Shared letters indicate there is no significant difference between groups. 
Numbers at the base of the column indicate sample size. 
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DISCUSSION 
Obesity and sleep fragmentation are often times concurrent conditions in patients 
with OSA (Shahar et al., 2001). Independently, both are known to be pro-inflammatory 
conditions, but there is limited information regarding the endocrine and immune 
consequences of simultaneous occurrence of both obesity and sleep curtailment. 
Currently, the only published experiment examining the interplay between obesity and 
sleep fragmentation is a behavioral experiment investigating the two within the context of 
pain sensitivity and anxiety (He et al., 2015). As a result, the findings of this experiment 
are novel in the field. Previous literature indicates that obesity increases the cytokine 
gene expression profile overall, with both pro-inflammatory (IL-1β, TNF-α, IFN-γ, IL-6, 
IL-12) and anti-inflammatory cytokine (IL-4, IL-10) levels being elevated in the serum of 
obese humans, chimpanzees, and mice (Fjeldborg et al., 2014; Nehete et al., 2014; 
Unnikrishnan et al., 2015). Additionally, it has also been demonstrated that sleep 
fragmentation results in augmented expression of IL-1β, TNF-α, CRP, IL-6, IL-8 in both 
the serum and adipose tissue of humans and rodents (Ciftci et al., 2004; Kent et al., 2011; 
Venancio and Suchecki, 2014). The effects of chronic low-grade inflammation, due to 
either obesity or OSA, have been demonstrated to contribute to the development of 
conditions such as metabolic syndrome, diabetes, hypertension, and cardiovascular 
disease (McNicholas et al., 2007; Ryan et. al, 2009; Zhang et al., 2014). Because obesity 
is a pro-inflammatory state, and because disruptions during sleep in patients with OSA 
further exacerbate inflammation, the summative effect of these two conditions has the 
potential to be increasingly detrimental on the physiological integrity of the organism.   
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In this study, obese and lean mice exhibited different immunological responses to 
acute sleep fragmentation. Obesity was the primary factor that increased the 
inflammatory environment, possibly creating a ceiling effect, by which inflammatory 
responses to SF were overwhelmed by the effects from obesity. Changes in cytokine gene 
expression were observed in all tissues of interest and the pro-inflammatory versus anti-
inflammatory expression profile was heterogeneous in various tissue locations. 
Simultaneous alterations in pro-inflammatory and anti-inflammatory cytokine gene 
expression were found in the liver (obesity), spleen (obesity and sleep), and cardiac 
muscle tissue (obesity). The inguinal adipose tissue (interaction) was dominated by a 
decrease in pro-inflammatory gene expression, while all 3 regions of the brain were 
characterized by a pro-inflammatory response attributable to obesity.  
Interestingly, in the spleen, fat, and heart, the gene expression of pro-
inflammatory cytokines (IL-1β and TNF-α) decreased with obesity. This result was 
surprising given the previous literature describing elevated circulating TNF-α, IL-6, CRP, 
IL-1β, and IFN-γ  associated with both OSA and obesity independently (Kent et al., 
2011; Nehete et al., 2014). However, despite this difference in the peripheral tissue, the 
immune response of the brain was dominated by increases in pro-inflammatory cytokines 
in hypothalamus, prefrontal cortex, and hippocampus, as a result of obesity. This increase 
supported previous literature detailing obesity induced states of neuroinflammation and 
association with psychopathologies (Aguilar-Valles et al., 2015; He et al., 2015). As a 
result, it can be concluded that in addition to having different responses between obese 
and lean individuals, our data seem to indicate a heterogeneous response in the brain and 
periphery, as a result of obesity. Previous literature suggests that the effects of OSA and 
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obesity on cytokine gene expression would be additive, due to the pro-inflammatory 
nature of the two factors independently (Unnikrishnan et al., 2015). However, based upon 
the decreased pro-inflammatory cytokine gene expression in the obese mice when 
compared to the lean in the spleen, fat, and heart, the results of this experiment support 
the hypothesis that neuroendocrine pre-adaptions exist in obese mice as a result of 
chronic exposure to the low-grade inflammation associated with obesity (He et al., 2015; 
Pak et al., 2014). 
Table 2. The effect of obesity on cytokine gene expression following SF. 
Tissue Effect  Factor  
Liver  
 
Increase: TNF-α and TGF-β1 Obesity 
Spleen Decrease: IL-1β 
Increase: TGF-β1 
Obesity  
Sleep 
 
Fat  Decrease: IL-1β 
Increase: TNF-α (sleep) 
Decrease: TNF-α (OB) 
Obesity and Interaction 
Interaction  
Interaction  
   
Heart Decrease: IL-1β and TNF-α 
Increase: TGF-β1 
 
Obesity 
Hypothalamus  Increase: IL-1β and TNF-α 
 
Obesity 
Prefrontal Cortex Increase: IL-1β 
 
Obesity 
Hippocampus Increase: IL-1β and TNF-α Obesity  
  
 Chronic SF has been shown to increase orexigenic behavior, while caloric 
expenditure remains unchanged, ultimately leading to weight gain from excess food 
intake (Carreras et al., 2015; Wang et al., 2014). Previous literature has indicated that 
these changes in weight gain are mediated by alterations in the expressions of leptin and 
ghrelin, satiety and orexigenic hormones, respectively, that act antagonistically on the 
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hypothalamus to maintain energy balance (Garcia-Garcia et al., 2014). Although the 
obese mice were leptin gene knockouts, both the sleep fragmented obese mice and lean 
mice lost significant body mass when compared to the control mice following acute sleep 
fragmentation. Consequently, this suggests that the alterations in orexigenic behavior 
following sleep curtailment are multifaceted and cannot just be explained by a 
simultaneous increase in ghrelin and decrease in leptin, at least in the short-term (Pak et 
al., 2014). Alternatively, the mass fluctuations following acute sleep fragmentation may 
also be impacted by the physiological stress response or increased locomotion during the 
pronged period of wakefulness. Furthermore, the amount of body mass lost due to acute 
sleep fragmentation did not depend upon the initial body weight, as the lean and obese 
mice lost similar amounts of body mass. The only factor affecting this observed 
difference was sleep. While weight gain is typically observed in chronic sleep 
fragmentation experiments involving mice, this weight gain is time dependent. The 
progression towards metabolic syndrome, characterized by reduced glucose clearance and 
reduced insulin sensitivity, does not impact body weight until after 2 weeks of 
experimentation (Carreras et al., 2014). As a result of the acute nature of this experiment, 
a body weight loss is observed in both the obese and lean HSF groups following sleep 
fragmentation. 
 Chronic exposure to sleep fragmentation and the hypoxic intervals associated 
with OSA result in the accumulation of cell damage (Pak et al., 2014). Cells in the 
pancreas, liver, heart, and adipose tissue have been hypothesized to be damaged due to 
oxidative stress and inflammation. Taken together, this damage explains the reduced 
insulin sensitivity, reduced glucose clearance, and disruption of elastic fibers in cardiac 
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vessel endothelium that have been observed with chronic sleep fragmentation (Carreras et 
al., 2014 ; Jia et al., 2014; Youn et al., 2014; Zhang et al., 2014). To counteract the 
negative effects of inflammation in the tissues most impacted by metabolic dysfunction, 
there must be some type of physiological anti-inflammatory response. It has been 
demonstrated that both pro-inflammatory and anti-inflammatory cytokines have increased 
expression in the tissue of obese individuals compared to lean individuals (Fjeldborg et 
al., 2014). The propensity toward an anti-inflammatory response could be protective in 
this case, as obese individuals would be at the greatest risk for the development of 
metabolic abnormalities (Youn et al., 2014). The simultaneous increase of pro-
inflammatory and anti-inflammatory cytokines in the liver tissue of obese mice supports 
previous literature that indicates an overall elevation in cytokine levels in the tissue of 
obese individuals compared to the lean counterparts (Fjeldborg et al., 2014). Because the 
liver is an essential insulin response tissue, the increase in anti-inflammatory cytokines in 
obese mice could be protective in preventing tissue damage due to chronic inflammation 
from obesity. Helping to further underscore the need to protect insulin-sensitive 
hepatocytes from inflammatory damage is the fact that it has been demonstrated that 
TLR-4 expression in the liver is important in regulating metabolic disorders, including 
inflammation and insulin resistance (Jia et al., 2014).  
In contrast to the increases in pro-inflammatory cytokine gene expression 
associated with both obesity and sleep fragmentation detailed in the literature, IL-1β gene 
expression decreased in both the spleen and inguinal adipose tissue as a result of obesity 
(Kent et al., 2011; Nehete et al., 2014). This finding directly opposes the increased IL-1β 
gene expression found in the fat in Chapter 1 and previous observations that have 
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characterized obesity as a pro-inflammatory state, with increases in both the potent pro-
inflammatory cytokines TNF-α and IL-6 (Pak et al., 2014). However, this discrepancy 
may be explained by the gene KO that was chosen for this experiment. Under normal 
physiological conditions, leptin is a pro-inflammatory signal that helps to support 
immune cell activation, proliferation, differentiation, and the production of pro-
inflammatory cytokines, including IL-1β and TNF-α (Besedovsky et al. 2012). Because 
the leptin gene is absent in the ob/ob KO mice, the normal effect of leptin on gene 
expression of IL-1β and TNF-α has been eliminated. Alternatively, the decrease in pro-
inflammatory cytokines following sleep fragmentation could also be a neuroendocrine 
adaptation in the obese mice to minimize tissue damage from the pre-existing pro-
inflammatory condition associated with obesity (Pak et al., 2014). As a potential 
protective mechanism, the obese mice could have reduced pro-inflammatory cytokine 
gene expression to protect important metabolic tissues, as previously mentioned.  The 
interaction between sleep and obesity also altered TNF-α gene expression in the adipose 
tissue. The effect observed due to sleep was similar to the results of previous experiments 
(Makki et al., 2013; Neto et al., 2010). The only observed alteration in cytokine gene 
expression as a result of sleep was observed in the spleen with TGF-β1. This result is 
surprising, given the previous literature implicating sleep fragmentation alone as a pro-
inflammatory condition (Ciftci et al., 2004; Kent et al., 2011). Again, because TGF-β1 is 
an anti-inflammatory cytokine, this increase suggests a potential preventative response to 
combat inflammatory damage due to acute sleep loss occurring in the spleen.  
In addition to the risk associated with the development of metabolic dysfunction 
resulting from sleep disruption, chronic sleep fragmentation can also lead to 
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cardiovascular alterations (Carreras et al., 2014; Kheirandish-Gozal et al., 2010; Zhang et 
al., 2014). Shortened sleep intervals unfavorably alter protein expression profiles, such 
that increases in the production of white blood cells, C - Reactive protein, IL-6 are 
observed, along with a simultaneous decrease in the anti-inflammatory cytokine IL-10 
(Gozal et al., 2008;  Kheirandish-Gozal et al., 2010; Mullington et al., 2009). Taken 
together with endothelial dysfunction and thickening and disruption of elastic fibers in 
the aortic arch and thoracic aorta as a result of sleep fragmentation, these changes 
unfavorably compound the risk for the development of cardiovascular disease (Carreras 
et al., 2014). Furthermore, left ventricle hypertrophy, pulmonary hypertension, diastolic 
dysfunction, and cardiac dilation attributed to obesity pose an additional independent risk 
for the development of cardiovascular disease (Otto et al., 2007). As a result, obese 
individuals with untreated OSA likely have a hightened risk for the development of 
cardiovascular disease, due to chronic exposure to inflammatory compounds. However, 
because this risk increases with cumulative exposure to inflammatory compounds over 
time, the results of an acute experiment may not be a direct link to replicate is occurring 
in these individuals. In lieu of this noted shortcoming, an acute model does provide 
insight into the initiation of the inflammatory response, which is vital in understanding 
the transition towards chronic pathology. Ultimately the results of the acute model are 
connected to what is occurring in a chronic model, but are not a direct link.  
Previous literature indicates that a combination of OSA and previous 
cardiovascular events results in increased inflammatory cytokine expression (Testlemans 
et al., 2013). Similarly, it is also reported that obesity alone increases inflammation and 
hypertrophy in the heart (Unsold et al., 2015).  However, in contrast to the increase in 
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pro-inflammatory cytokines that would be expected, there was a decrease in IL-1β and 
TNF-α in cardiac muscle tissue, observed with a simultaneous increase in TGF-β1, all 
attributable to obesity. The increase in the anti-inflammatory cytokine supports previous 
findings in which the entire cytokine gene expression profile was elevated in the tissue of 
obese individuals compared to that of lean individuals and also supports modulation of 
the inflammatory response to prevent damage to vital tissue (Fjeldborg et al., 2014).  
After a chronic period of sleep loss, the onset of cardiovascular disease is proposed to be 
a consequence of damage due to a pathway involving oxidative stress induced by the 
products of the NOX-2 enzyme of macrophages (Carreras et al., 2014; Zhang et al., 
2014). The heightened TGF-β1 gene expression in the cardiac muscle tissue of obese 
individuals again suggests the presence of a protective response against cardiac 
inflammation. Additionally, the decrease in pro-inflammatory cytokines can be attributed 
to the absence of leptin in these animals and is therefore a consequence of the gene KO 
that was chosen. The observed alterations in cytokine gene expression in this experiment 
were detected at the mRNA level. Previous experimentation has shown that mRNA and 
protein expression levels of TNF-α are correlated following experimental sleep loss and 
vaccine stimulation. However, experiments involving IL-1β have produced conflicting 
results and TGF-β1 has not been studied within this context (Irwin et al., 2006, Shebl et 
al., 2010). Consequently, it is equivocal whether protein levels correlate directly with 
mRNA expression, but nonetheless, increased mRNA expression still provides insight 
into the rapid temporal dynamics of cytokine activation at the transcriptional level. 
 Sleep fragmentation altered serum corticosterone concentration independently of 
initial body mass. Both the lean and obese HSF groups exhibited increased serum 
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glucocorticoid concentrations, but there was no difference detected between these two 
groups. This result supports the findings of the previous experiment in Chapter 1 and also 
replicates previously reported increases in serum corticosterone following varying times 
of sleep deprivation (Ashely et al., 2013; Bonnavion et al., 2015; Neto et al., 2010). 
Although the ob/ob mice are known to exhibit hypercorticosteronemia, the serum 
corticosterone concentrations of the obese mice were not found to be different from those 
of the lean mice in this experiment. The corticosterone concentrations may be 
biologically elevated in the obese mice, but there was no statistically significant 
difference between the two mouse strains.  
 In rodents, it has been demonstrated that leptin inhibits release of stress hormones 
by means of the HPA-axis and that deficiency in leptin affects HPA signaling, resulting 
in HPA-hyperactivation (Bonnavion et al., 2015). Because the ob/ob mice are leptin 
knockouts, it would be expected that excess circulating corticosterone could impact the 
experimental results, through the anti-inflammatory action of glucocorticoids. However, 
because there is no difference between the lean and obese serum corticosterone 
concentrations, hypercorticosteronemia cannot fully explain the decreased cytokine gene 
expression due to obesity, indicating that these observed differences are due to obesity or 
other physiological variables associated with obesity, such as insulin concentration.  
Furthermore, the increase in serum corticosterone concentration and mass loss as a result 
of HSF in both the lean and obese mice suggest the animals are experiencing a 
physiological stress response. Alternatively, increases in serum corticosterone 
concentration could have been attributed to a shift in natural biological rhythms from 
forced arousals during the light phase of the LD cycle or to an increase in activity levels 
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in the SF groups as a result of tactile stimulation from the swipe bar. The combination of 
body mass loss and simultaneous increase in serum corticosterone concentrations suggest 
that HSF mice were experiencing a physiological stress response, including activation of 
the HPA axis, as a result of sleep interruptions occurring so frequently. However, it is 
unclear whether HPA activation occurred because of the method of sleep fragmentation 
used or the direct effect of disrupted sleep per se.  
The majority of previous experiments investigating the effect of sleep loss on the 
immune system have utilized experimental models simulating either OSA or obesity, but 
have not used a model that combines the two conditions. Chronic sleep interruptions from 
OSA influence overall the restfulness of sleep and have been shown to induce an acute 
inflammatory response (Gozal et al., 2008; Kent et al., 2011; Pulixi et al. 2014). 
Similarly, obesity is also known to be a pro-inflammatory condition, with adipose tissue 
exhibiting an endocrine function and secreting pro-inflammatory cytokines and other 
adipokines into the bloodstream (Ryan et al., 2009). Due to the pro-inflammatory nature 
of both conditions, it can reasonably be concluded that when both conditions exist 
concurrently, there will be some type of inflammatory response initiated; however, this 
response has yet to be characterized.  
It is known that sleep fragmentation has differential effects on the behavior of 
lean and obese mice, but there has been no investigation into effects upon immune 
function (He et al., 2015). Because obesity and sleep fragmentation associated with OSA 
often times occur simultaneously, there is a need to understand the interplay between the 
pro-inflammatory responses resulting from both conditions. Furthermore, if the resulting 
inflammatory response is different within the context of obesity, this may suggest that 
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obese and lean individuals suffering from OSA may be responding to the disease and 
treatments differently. In the present study, we provide compelling evidence in support of 
differential cytokine gene expression between lean and obese mice and found that this 
response was heterogeneous based upon tissue location. Because the results of this 
experiment suggest that the absence of leptin may be affecting cytokine gene expression 
in the obese mice, this experiment should be replicated within the context of a diet 
induced model of obesity to tease out the effects of leptin. Despite this, the current results 
suggest that a pro-inflammatory environment was induced in the brain of obese mice, 
while a protective anti-inflammatory environment was produced in the periphery of the 
same animals, all within the context of heightened serum corticosterone concentrations.  
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APPENDIX A: SUPPLEMENTAL FIGURES 
 
 
Figure 14. The Model 80391 Sleep Fragmentation Chamber that was used for this 
experiment (Lafayette Industries).  
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Figure 15. 8 week old male ob/ob KO mouse before and after dissection. 
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Figure 16. Male littermates from breeding of heterozygous ob mice at 8 weeks of age. 
From left to right, the mice are homozygous dominant, heterozygous ob, homozygous 
recessive ob/ob knock out (obese mouse). 
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